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ABSTRACT 
CHEMICAL BIOLOGY-BASED PROBES FOR THE DETECTION OF RECEPTORS 
ON LIVE CELLS 
 
SEPTEMBER 2015 
 
AMANDA M. HUSSEY  
 
B.S., UNIVERSITY OF THE SCIENCES IN PHILADELPHIA 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor James J. Chambers 
 
 
Proper detection is the key to studying any processes on the cellular scale.  
Nowhere is this more evident than in the tight space which confines the synaptic cleft. 
Being able to ascertain the location of receptors on live neurons is fundamental to our 
understanding of not only how these receptors interact and move inside the cell but also 
how neurons function.  Most detection methods rely on significantly altering the receptor; 
both tagging with a fluorescent protein or targeting the receptor by a fluorescent reporter 
in the form of a small molecule causes significant difficulties. These localization 
techniques often result in forced dimerization, unnatural movement, and at worst 
inactivation of the receptor.   
Small molecule organic dyes provide a potential advantage because they can be 
structurally functionalized to target the protein of interest in a non-perturbing fashion 
which allows for information to be gathered about the targeted receptor. The work I 
initiated in the Chambers lab first focused on using a ligand directed fluorophore 
connected via a photo-labile linker.  Through the use of epifluorescence microscopy, I 
determined that this probe targets glutamate receptors, however questions about subtype 
inclusion could not be addressed. 
  
 
vii 
  The pharmacophore that our first probe is based on could be much more 
promiscuous than is presently appreciated in the field of neurobiology.  Thus, we 
designed a new series of probes to allow for covalent modification and affinity 
purification of endogenous receptors. The second generation of probes set out to answer 
the questions left by the first. Purified proteins were subjected to SDS-PAGE analysis 
and could be applied to proteomic identification of receptors. 
  In addition to ligand directed probes, we have also initiated a project on a new, 
bimolecular photoaffinity probe in which the new methodology continues to develop. The 
initial studies were performed to ensure that our new strategy is able to be used in 
biological systems.  
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CHAPTER 1  
INTRODUCTION 
Portions of this chapter have been published as Hussey, A.M. and Chambers, J.J. ACS Chem. 
Neurosci. 2015 6(1), pp189-98 
1.1 Neuronal Structure 
   The brain is a complex organ composed of 1,000,000s of neurons which interface 
with each other in order for the body to function.  Neurons are post-mitotic, highly 
polarized cells which transmit information through chemical and electrical signals.    
Neurons contain three major morphological regions: a soma, or cell body, which contains 
the nucleus and other cytoplasmic organelles, a single axon which extends from the cell 
body to transmit neuronal information, and numerous dendrites which may be spiny or 
non-spiny which receive information. (Figure 1.1)1 
 
 
Neurons communicate via transfer of electrochemical signals from the axon 
terminal to the dendrites. This area is called a synapse.  The axon terminal of one neuron 
acts as the presynaptic portion of the synapse, while the dendrite acts as the post-synaptic 
portion.  The space in-between is the synaptic cleft, which measures to be about 20 nm in 
Figure 1.1: Annotated image of a neuron 
  
 
2 
size.2 It is in this area where neurotransmitter receptors reside and synaptic 
communication takes place. 
1.1.2 Synaptic Communication and Plasticity 
Neuronal communication involves the transfer of neurotransmitter from the pre-
synaptic side of one neuron to the post-synaptic side of another neuron.  It is on the post-
synaptic side where neurotransmitter receptors and ion channels reside. (Figure 1.2)  
 
 
 
 
 
How the synapse strengthens or weakens in response (e.g. the addition or 
removal of neuronal receptors from synapse) to a chemical response is termed synaptic 
plasticity, which can be controlled on either side of neuronal communication.  On the 
presynaptic side, the flow of neurotransmitter can be regulated.  On the postsynaptic side, 
the type and density of receptors is regulated.  Regulation on the post synaptic side either 
adds more neuronal receptors, known as long term potentiation (LTP), or removes 
Figure 1.2: Cartoon image of synaptic communication. Neurotransmitter flows 
from the pre-synaptic side of one neuron to the post-synaptic side of 
another. Neuronal receptors reside on the postsynaptic side to receive 
the neurotransmitter. Reprinted with permission from Hussey, A.M. and 
Chambers, J.J. ACS Chem. Neurosci.2015 6(1), pp189-98. Copyright 
2015 American Chemical Society. 
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receptors, known as long term depression (LTD).3 Both LTP and LTD are thought to 
underlie memory formation in the brain. α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid receptors (AMPARs) are the critical receptors which mediate fast 
excitatory synaptic processes during LTP.  Thus, the mechanism of how these receptors 
are trafficked is of fundamental importance.  
1.1.3 Long Term Potentiation 
LTP involves the insertion into the plasma membrane and the rapid recycling of 
AMPARs through the endosomal systems (Figure 1.3).  Until very recently, LTP was 
thought to be mediated by the insertion of GluA1-containing AMPARs into the synaptic 
membrane, thus, there is a large amount of characterization of these processes.  The 
combination of calcium being tightly regulated by all cells and the low abundance of 
calcium permeable AMPARs on the surface lead to the thought that these receptors play a 
minor role in LTP. However, calcium permeable AMPARs have now been shown to  
play a larger role than originally thought in LTP, though the mechanism of how is not 
well understood.4 
A key player in long term potentiation is phosphorylation of AMPARs by protein  
kinases.5 One particular class of kinases thought to be important in LTP are the 
Ca2+/calmodulin-dependent protein kinases (CaMK), specifically, CaMKII. AMPAR 
conductance is increased when CaMKII phosphorlylates GluA1 at S831 directly which 
may induce LTP.6 Another key kinase is protein kinase A (PKA), which phosphorylates 
GluA1 at S845. Phosphorylation at this latter site allows for the increased chance of the 
channel opening, thus more neurotransmitter to go through the channel.7 Phosphorylation 
of GluA1 S845 also allows for some of the delivery of GluA1 to synapses, as well as to 
the extrasynaptic membrane.8 Synaptic associated protein 97 kDa (SAP97) is in the 
PSD95-like membrane-associated guanylate kinase family, and has been found to be 
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important during LTP.  It binds to the C-teminus of GluA1 and plays a role in the 
phosphorylation of GluA1, leading to enhancement of LTP.5b 
 
 
 
In pyramidal neurons, LTP induces transient and rapid insertion of GluA2-
lacking calcium-permeable AMPARs into the membrane presumably to enhance the 
received signal from the presynaptic terminal.9 The exact mechanisms of how calcium 
permeable AMPARs are trafficked to the surface are still under investigation. Addiction 
studies with cocaine in mice have shown there is an increase in the number of calcium 
permeable AMPARs found at the synaptic membrane after initial drug-dose exposure. It 
is believed that the overall number of AMPARs does not increase; rather, calcium 
Figure 1.3: Cartoon of LTP. The pre-synaptic side of one neuron releases 
neurotransmitter to the post-synaptic side of another. This is thought to be 
pivotal in memory formation. 
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permeable ones replace calcium impermeable ones. This creates a long-lasting plasticity, 
even after a single injection, possibly underlying some of the addictive seeking 
behavior.10 
1.1.4 Long Term Depression 
LTD is the removal of AMPARs from the plasma membrane. This can be done 
through either endocytotic processes or internalization of the receptors.  Endocytosis can 
be done through a clathrin–dependent method in which the AMPARs are removed for 
possible intracellular sorting.11 The mechanisms of LTD are harder to pin down, as most 
evidence shows that LTD is caused by endocytosis of AMPARs. However, there are 
many factors that could cause endocytosis and internalization resulting from provocation 
from stimuli such as calcium influx, calcineurin, synaptic activity, ligand binding, and 
insulin influx. These stimuli can result in synaptic vesicle endocytosis and endocytosis of 
AMPARs to the early endosome, which can be hard to differentiate from that caused by 
LTD in cultured cells. 8, 11-12 
 
Figure 1.4:  Cartoon of LTD. Fewer receptors are present on the 
surface of the post-synaptic side of the receptor. It is a synaptic 
pruning process which occurs during sleep. 
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Glutamate receptor interacting proteins (GRIP1 and GRIP2) are another class of 
proteins which aid in trafficking of AMPARs during synaptic plasticity. In LTD, 
phosphorylation of S880 and Y886 on GluA2 disrupt the binding of GRIP1, allowing for 
internalization of AMPARs, thus reducing the numbers in the synapse.13 GluA2 can also 
interact with clathrin adaptor protein AP-2, which leads to the NMDA-induced 
internalization of AMPARs in an LTD like fashion.8 PICK1 is another protein that plays 
a role in the LTP/LTD cascade.  The interaction GluA2 and PICK1 is critical in leading 
to LTD 14, thus prompting the idea that PICK1 removes GluA2 containing AMPARs 
from the synapse.15 
1.1.5 Glutamate Receptors 
 
There are many classes of neurons including inhibitory, excitatory, and 
neuromodulary. Both inhibitory and excitatory neurons can be further broken down into 
neurons that make local contacts and those that make distant contacts.1 Inhibitory neurons 
include GABAergic neurons, medium spiny neurons in the basal ganglia and Pukinje 
cells, just to name a few. These neurons are characterized by small, localized projections 
which help to regulate excitatory neurons. Excitatory neurons include pyramidal neurons 
and spiny stellate neurons found in the cortex. These cells project both locally in the 
cortex and make long range connections into different neuronal areas. They are 
responsible for carrying the electrochemical communications within the brain.1 
Fast excitatory glutamatergic transmission is exclusively mediated in the central 
nervous system (CNS) by ionotropic glutamate receptors (iGluRs). These include kanaite 
receptors (KA), n-methyl-d-aspartate receptors (NMDARs), and α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptors (AMPARs).  IGluRs are characterized as 
tetramers which are encoded by 18 genes. Several of these genes undergo alternative 
splicing and RNA editing.  All iGluRs are encompassed by three distinct domains: an 
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extracellular N-terminus, a central transmembrane domain, and an intracellular C-
terminus domain (Figure 1.5).8, 16 
 
 
 
 Figure 1.5: Cartoon representation of iontropic glutamate receptor in the membrane. All iGluRs follow the same orientation with the N-terminus and ligand 
binding domain in the extracellular space, four transmembrane domains, and 
the C-terminus in the intracellular space. 
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1.1.6 Kainate Receptors  
Kainate receptors are a subclass of glutamate receptors named for their activation 
by the synthetic agonist kainic acid (Figure 1.6). They are tetramers of GluK1-GluK5 and 
their main function is to modulate neuronal excitability and synaptic transmission. They 
differ from other ionotropic glutamate receptors, as they are located in pre-synaptic 
terminals rather than the post-synaptic terminals.16a Kainate receptors are generally 
calcium impermeable, but there is evidence of a calcium permeable form. 
1.1.7 NMDARs 
NMDARs are named for their activation by the synthetic analogue of glutamate, 
n-methyl-d-aspartate (Figure 1.6), and are important regulators of synaptic plasticity.  
They form obligate heteromers of GluN1, GluN2A-GluN2D, GluN3A, or GluN3B in a 
tetrameric fashion. Channel composition combinations include two GluN1 and two 
GluN2A-GluN2D subunits, and two GluN subunits with one GluN2A-D subunit and one 
GluN3 subunit. Once assembled, they act as Ca2+ permeable channels, which require both 
Figure 1.6: Structures of glutamate analogues AMPA, 
NMDA, and kainic acid 
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glutamate and glycine for activation.16a NMDA receptors are blocked by extracellular 
Mg2+ ions which blocks the channel so that there is little ion flux through it in the absence 
of post-synaptic depolarization, allowing for a crucial role in activity dependent synaptic 
communication.17 
1.1.8 AMPARs 
AMPA receptors are named for their sensitivity towards the glutamate analogue 
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (Figure 1.6). They are the most 
abundant of the ionotropic glutamate receptors and mediate excitatory neurotransmission. 
They assemble as either homo or heterotetramers of GluA1-GluA4, which share 68-73% 
sequence identity.18 The most common of the tetrameric pairings are those containing 
GluA1-GluA2 and GluA2-GluA3.8 AMPARs have some calcium permeability (discussed 
in section 1.1.9) and are impermeable to Mg2+.16a AMPARs have an inwardly rectifying 
current, which can be blocked by the application of polyamine toxins (described in 
section 1.1.11). 
Like other glutamate receptors, AMPARs contain an extracellular N-terminus, 
central transmembrane domain, and intracellular C-terminus. The central transmembrane 
domain can be further broken down into three distinct transmembrane portions M1, M3, 
and M4, as well as an M2 hairpin structure which changes the direction so it returns to 
the intracellular side of the cell (Figure 1.5).8, 18 There are two subforms of each subunit, 
referred to as “flip” and “flop”, as they vary by an interchangeable 38 amino acid 
sequence before the M4 transmembrane portion.18-19 
     Assemblies of AMPARs start in either the endoplasmic reticulum (ER) or the 
Golgi apparatus and are trafficked to the plasma membrane. In the ER, the C-terminus is 
subjected to palmitoylation, phosphorylation, and ubiquination for regulation. The C-
terminus is also the site where signaling molecules (such as protein interacting with 
kinase C, PICK) and cytoskeletal proteins (such as kinesin) bind, aiding in insertion into 
  
 
10 
either the soma or synapses.3, 20 These receptors are then in a dynamic equilibrium with 
the synapse.17, 20 The amount of receptors is variable dependent upon location and cell 
type, and is also dependent upon endo and exocytosis at the postsynaptic membrane.3, 8 
AMPARs are known to move in endosomes in a recycling process that first involves 
endocytosis of the receptor, then entry into the endosomal system, and then final 
movement back to the receptor surface.4 
AMPAR assemblies are controlled not only by posttranslational modifications, 
such as phosphorylation of key residues on the individual subunits, but also by regulatory 
proteins. One of the key classes of proteins to act as AMPAR regulators are 
transmembrane AMPAR regulatory proteins (TARPs). There have been many TARPs 
identified, including stargazin (ɣ-2), ɣ-3,-4,-5,-7, and -8.21 Each AMPAR is thought to 
contain 1-4 TARPs for stabilization of their pore, and each TARP influences the behavior 
of the particular AMPAR.21a, 21c Stabilization of synapses by TARPs is via interaction 
with PSD-95 and other membrane-associated guanylate kinases (MAGUKs) that are 
present, as TARPs bind to the PDZ domain on each.22 TARPs influence AMPAR 
behavior in a variety of ways including increasing single channel conductance, slowing 
deactivation and desensitization, modification of pharmacological properties by making 
kainate a better agonist, and, perhaps most importantly to this dissertation, attenuating 
voltage-dependent blocks by endogenous polyamines.21a, 23 TARPs are also involved in 
AMPAR trafficking, as they promote AMPAR maturation, cellular delivery and 
clustering, and are most likely involved in both LTP and LTD.21a-c 
AMPARs can insert themselves into the membrane in a couple of different 
fashions. First is through kinesin directing endosomes containing AMPARs, and the 
second is through vesicle fusion events with SNARE proteins on the surface of the 
membrane.24 Once the AMPAR cargo is delivered, the receptor can travel to an active 
spine via lateral diffusion.25 
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1.1.9 Calcium Permeability in AMPARs 
AMPA receptors can either be calcium permeable or calcium impermeable.  
Those receptors that contain GluA1, GluA3, and Glu4 combinations are calcium 
permeable.  Ones which contain GluA2 are generally calcium impermeable. There is a 
subclass of calcium permeable AMPA receptors which contain unedited GluA2 
receptors, which have been thought to be pivotal in some disease states, such as 
amyotrophic lateral sclerosis (ALS). The calcium permeability of GluA2 is mediated by a 
single RNA codon edit known as the Q/R site inside the M2 domain of the subunit. Here, 
an encoded glutamine is changed to an arginine via a single nucleoside edit.  In the 
nucleotide code, CAG (glutamine), the encoded adenosine is changed to inosine (CIG), 
which is read as CCG (arginine). This edit is mediated by the enzyme adenosine 
deaminase acting on RNA (ADAR2), as it recognizes the Q/R site through the formation 
of a duplex structure of the editing site and the editing site of the complimentary 
sequence.26  This edit occurs postnatally and accounts for only about 1% of the GluA2 
RNA.  ADAR2 activity is important as ADAR2 knock out (KO) mice die very young 
from epilepsy due to the increased amount of calcium influx from the larger population of 
unedited GluA2. 18, 27 It is important to note that AMPARs which do contain unedited 
forms of GluA2 may be very effective at inducing neurotoxicity, suggesting their role in 
the disease states mentioned in section 1.4. 28 
The populations of calcium permeable AMPA receptors are not consistent or 
uniform, but are highly dependent on developmental stage of the neurons as well as cell 
type.  For example, inhibitory interneurons contain larger amounts than that of mature 
excitatory neurons.17, 29 However, immature excitatory neurons (e.g. postnatal culture) 
have high populations of calcium permeable AMPARs.30 The number of calcium 
permeable AMPARs can increase due to pathological and physiological conditions found 
in the brain, meaning that in times of stress and disease, their numbers can increase 
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greatly. This induced stress from the extra calcium makes it harder for the neuron to 
regain normal function thus they might perish. 
Calcium permeable AMPARs, unlike NMDARs, are not subject to blocks by 
extracellular cations, such as Mg2+, but are subject to voltage dependent block by 
polyamines.  They are also permeable towards other divalent cations, specifically Zn2+.  
Zn2+ is toxic to neurons and can enter through calcium permeable channels. The entry of 
Zn2+ can lead to ischemic like injury and neurodegeneratation.17, 31 
1.1.10 Calcium Permeable AMPA Receptors in Excitatory Disease 
AMPA receptors are involved in a number of disease states. This is influenced by 
a number of factors including influx of calcium, certain drugs (such as cocaine), disease 
progression, and ischemic trauma. 
Forty percent of patients, who are being treated with l-DOPA for Parkinson’s 
disease, and other similar diseases, will develop l-DOPA induced dyskinesia which is 
linked to pathological corticostriatal synaptic plasticity such as altered expression of 
striatal opioid peptides. This presents enhanced corticostriatal glutamatergic transmission 
by which the mechanism and expression of l-DOPA induced dyskinesia plays a critical 
role.  Animal studies have shown that AMPARs may be present during these induced 
dyskinesias as enhanced trafficking and phosphorylation of AMPARs in the striatum was 
present.32 
More recently, GluA2 containing calcium permeable AMPA receptors have been 
implicated as a potential cause of ALS.  ALS has a couple of different disease 
phenotypes; the most well studied being the familial form which has defects in copper 
zinc superoxide dismutase 1 (SOD1) known as ALS1.  Familial cases of ALS only 
compose 10% of all new ALS diagnoses, so there is ultimately another mechanism, or 
mechanisms, of how the disease initiates and progresses.  It is also noteworthy that the 
death inducing molecular mechanisms differ between sporadic ALS and ALS1, as those 
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who have sporadic ALS do not share the same disease causative mutations that are 
characteristic of ALS1. Also, those who have ALS1 lack the accumulation of TDP-43 
(transactive response DNA binding protein 43 kDa), a transcriptional protein whose 
ubiquinated, phosphorylated form is a marker for ALS 33 which is seen in patients having 
sporadic ALS. 27 Transgenic animal studies have suggested a role of GluA2 containing 
calcium permeable AMPA receptors as there is a large amount of motor neuron loss in 
these animals. Crosses of SOD1 mutant mice and mice which contain a nonlethal calcium 
permeable GluA2 edit (asparagine in the Q/R site) lead to acceleration in the disease.27, 34 
Analysis of brain samples from ALS patients after autopsy show a decreased amount of 
ADAR2 mRNA in the ventral grey matter compared to those of who are non-
symptomatic for ALS, thus showing a possible correlation of ADAR2 reduction and 
motor neuron death due to inefficient editing of the Q/R site.27 
Calcium permeable AMPARs are involved in brain ischemias, or loss of blood 
flow to the brain leading to reduced metabolic rates, and ultimately total neuronal death. 
When present in early brain development, there is an increased rate of neuronal death in 
the white and grey matter coinciding with the times that there are a marked increase in 
the numbers of calcium permeable AMPARs present, suggesting the link of these 
receptors to ischemic susceptibility.35 Ischemia can also be present after cardiac arrest, 
resulting in damage to, and potential loss of, of neurons. Pyramidal neurons in the 
hippocampus are particularly vulnerable to this type of injury. The amount of calcium 
permeable AMPARs rises after ischemia, resulting in a greater injury due to the ischemic 
event, and ultimately neuronal death due to the induction of Ca2+ permeability.17, 36 
1.1.11 Polyamine Toxins as Tools in Neurobiology 
Polyamine toxins have become a key tool as antagonists of calcium permeable 
AMPA receptors. AMPA receptors, specifically calcium permeable ones, are subjected to 
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voltage dependent blocks by polyamines, but are not blocked by extracellular cations.  
This allows for the free flow of Ca2+ through the channel.37 
Polyamine toxins (Figure 1.7) are low molecular weight secondary metabolites 
which have mainly been isolated from the venom of spiders and wasps. These toxins are 
not deadly; rather they have a reversible paralytic effect. Argiotoxin-636 (Arg-TX-636) 
was the first isolated polyamine toxin isolated from the venom of the orb weaver spider.  
Next came Joro spider toxin (JSTX-3), isolated from the spider of the same common 
name.  The venom of the Egyptian digger wasp was known to block iGluRs since the 
early 1980’s, its isolation of the active component, philanthotoxin-433, provided another 
toxin.38  All of these toxins share two structural moieties in common; an aromatic head 
group and a polyamine tail, which then enabled the synthesis of napthylacetylspermine, a 
synthetic polyamine.39 All act as open-channel ion blockers of iGluRs, are use-dependent, 
and voltage-dependent coming from the polyamine blocking the inward current of the 
AMPAR channel. The use-dependence comes from the ion channel needing to be open 
for targeting by the exogenous polyamine application. It is important to re-iterate that this 
is true of all AMPARs which do not contain an edited GluA2 subunit. The presence of 
the arginine in the channel will not allow for binding of the polyamine into the ion 
channel due to charge repulsion.38a, 40 
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Binding of polyamine toxins to ion channel pores has been explored through a 
variety of molecular modeling and structure-activity experiments as there is no X-ray 
crystal structure data available for precise details of the full AMPA receptor.  However, a 
crystal structure is available of the GluA2 subunit.41 From the collected data, polyamine 
toxins are suggested to bind so that the polyamine tail binds into the ion pore and the 
acryl head acts as a block to the ion channel.42 
1.2 Imaging Techniques 
Small molecule fluorophores and proteinaceous fluorophores have been the main 
tools used in the visualization of ion channels, neuronal receptors, and other targets on 
live neurons. The main methods for visualization can be divided into two broad 
categories; genetic methods and non-genetic methods. Genetic methods involve encoding 
the receptor of interest to produce either a fluorescent reporter or a small tag for  
Figure 1.7: Structures of polyamine toxins with activity towards AMPARs.  
The common moieties of the aromatic acyl head group and the 
polyamine tail are pointed out in the box 
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attachment of a fluorophore. Non-genetic methods involve the delivery of biological or 
small molecule reporters for visualization.  This can be summarized by Figure 1.8 
  
 
 
1.2.1 Genetic Imaging Techniques 
Genetic imaging techniques have benefited greatly from the discovery of 
fluorescent proteins (FPs).  FPs can be encoded into to the DNA of a protein of interest 
which can then be transfected into a cell. Recently, FPs have been used to visualize 
neurons and glia in 90 different colors in zebrafish, drosophila, and mice in a technique 
known as Brainbow, which allows for the serial reconstruction of connectivity through 
the stochastic expression of cytosolic FPs. This is done through a Cre/Lox recombination 
which determines the pattern and colors that are expressed, allowing for the visualization 
of neuronal connectivity in a given system.43 FPs are more commonly used as fluorescent 
fusion proteins which are then transfected into a particular system of interest, thus 
Figure 1.8: Size comparison of common protein tags. All of the common protein tags for 
visualization of neuronal receptors (antibodies, GFP, HaloTag, Snap Tag, quantum 
dots, and tetracysteine motifs) have been scaled relative to the size of an AMPAR. 
The size comparisons for small molecule organic probes are in the right panel. 
Reprinted with permission from Hussey,A.M. and Chambers, J.J. ACS Chem. 
Neurosci. 2015 6(1), pp189-98. Copyright 2015 American Chemical Society. 
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allowing for the visualization of the receptor of interest as the protein is covalently tagged 
to the protein of interest. This has been done numerous times to determine receptor 
surface expression, how receptors are endo/exocytosed, and to interrogate the biophysical 
properties of a particular ion channel.43b, 44 Fusion proteins can be quite small, but most 
are based on the GFP (green fluorescent protein) template developed by Tsein et al.45 
1.2.2 Fluorescent Proteins 
GFP ushered in a new age in which many biological advances have and can be 
made.  GFP, itself, is a 28 kDa protein which is added to the receptor of interest in a 
fashion which allows for the particular receptor to still remain functional.  This is done by 
adding GFP as either a fusion to the N or C terminus or added into a loop on the protein.  
This can then result in non-native heteromultimers or homomultimers when the receptors 
assemble.  Also, the addition of GFP (and variants) can disrupt normal receptor motion, 
which will provide no information about receptor dynamics.43b, 46 
1.2.3 Enzymatically Active Tags 
One way to circumvent some of the issues presented by FPs, is to use 
enzymatically active tags such as SNAP, CLIP, and Halo tags.  SNAP and CLIP tags 
involve the incorporation of a derivative of O6-alkyl guanine-DNA alkyltransferase 
(AGT), a 20 kDa DNA repair protein, which can be inserted to the protein of interest.  
For SNAP-tag technology, modifications to the protein are delivered via the intrinsic 
activity of the tag and synthetic derivatives of O6-benzylguanine that have been modified 
to contain cargo such as fluorophores.47 O6-benzylguanine probes act as a substrate to the 
tag, delivering cargo to a reactive cysteine in the AGT active site. CLIP-tag reacts in the 
same fashion, but contains mutations to AGT so that it will interact with derivatives of 
O2-benzylcytosine.48 SNAP and CLIP tags have been used in numerous systems to track 
subunit assembly and stoichiometry. Much like FPs, SNAP and CLIP tags suffer from the 
same issues of complications in the natural assembly and protein dynamics. 
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HaloTag is a labeling technology that is derived from modified bacterial 
haloalkane dehalogenase. It is a large tag, approximately 34 kDa, and needs to be 
attached to the protein of interest via a 16 amino acid linker derived from the tobacco 
mosaic virus.49 Once fused to the protein of interest, HaloTag is targeted by a separate 
reporter probe containing a haloalkane. HaloTag works by alkylation of the reporter 
probe to the protein of interest affixed with HaloTag, resulting in the formation of an 
ester bond at a catalytic aspartate on the carboxylate. The modification that allows for 
this to happen is a mutation of a crucial histidine near the catalytic aspartate leaves the 
transient covalent ester intact, allowing for the reporter probe to attach to HaloTag.50 The 
linker length between the haloalkane and the reporter (fluorescein, tetramethylrhodamine, 
Alex 288, Dy633, Oregon green, etc.) is crucial for the optimum performance of 
HaloTag. The optimal linker length was found to be six carbons, when terminated with a 
chloride. HaloTag has been utilized to measure retrograde axonal transport and to look at 
some of the basis of cell mediated autophagy.43b, 51 HaloTag suffers from the same 
disadvantages as FPs, SNAP and CLIP tag, however it has been reported that the large 
tag size does not disrupt protein function.52 
Similar to enzymatically active tags are enzymatic substrate tags.  This 
technology was pioneered by the Ting lab and involves the attachment of a 15 amino acid 
acceptor peptide to the protein of interest and then is targeted by a substrate sequence that 
is exogenously expressed biotin ligase resulting in bioconjugation of a peptide with biotin 
which then can be targeted by a streptavidin labeled moiety. This biotin ligase based 
strategy has been used in conjunction with HaloTag for use in single molecule live cell 
imaging.53 
1.2.4 Small, peptide-based tags 
The use of small, peptide based tags is another genetic technique that averts the 
need for FPs or enzymatic tags.  These include tetracysteine motifs, poly-histidine tags, 
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and Ni-NTA tags. The most widely used of the small, peptide tags are tetracysteine 
motifs. Tetracysteine motifs, as the name suggests, insert a small peptide sequence which 
contains four cysteines (C-C-X-X-C-C) to the protein of interest in a non-perturbing 
fashion.  The added tetracysteine sequence can then be targeted by a fluorophore which 
contains a biarsenical core, taking advantage of the high affinity between the sulfurs in 
the cysteine and the arsenic. This can then allow for the location and dynamics of the 
protein to be measured. Tetracysteine motifs are also used because there is generally a 
lack of arsenic in proteins, and the multivalency that is given between the four encoded 
cysteines to a single arsenic in the reporter.54 The biarsenical reporter tag comes in a 
variety of colors, including green, red, and blue (FlAsH, ReAsH, and XoXAsH).54-55 In 
2007, Bhunia et al expanded the pallet even further through the use of SplAsH, which can 
incorporate a fluorophore of any color on to the arsenic core.56 
Tetracysteine motifs have been used in conjunction with FlAsH in imaging using 
either chromophore-assisted laser inactivation (CALI) or fluorophore-assisted laser 
inactivation (FALI), which allows for perturbations to the system and collect 
observations from that set time point.57 FlAsH and ReAsH have been used in 
combination to examine the intracellular trafficking of GluA1 and GluA2 subunits.  This 
was done by inserting the tetracysteine motif on the C-terminus and thus could report on 
protein synthesis in these two subunits.58 
Tetracysteine motifs do have some caveats, chiefly that there is a low level of 
specificity when using the whole system in cysteine rich environments. The biarsenical 
detection ligand does not discriminate between that of the added tetracysteine motif and 
the endogenous cysteine rich areas on the protein. This can lead to misdirection of the 
biarsenical targeting ligand; thus confounding the imaging outcome as it will be a 
mixture of the desired protein and the non-desired cysteine rich one.43b 
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1.2.5 Antibodies 
Antibodies are exquisitely specific towards their target of interest and thus are an 
extremely useful diagnostic tool for protein interactions. Antibodies are the bridge 
between genetic and non-genetic techniques as they contain aspects from each.  
Antibodies are genetic in the sense that they are derived from proteins raised to label a 
specific epitope on the protein of interest.  Antibodies are non-genetic as they need to be 
exogenously applied to label the protein of interest, and also may need a secondary 
detection for visualization.43b 
The use of antibodies mostly involves no genetic manipulation to the protein of 
interest when the antibody is raised towards a particular epitope on the receptor.  
Antibodies have been used in both live and fixed cell imaging with neuronal targets 
providing information on location, quantification, and observation of the dynamic 
movements of the neuronal receptors. Antibodies are large proteins, typically measuring 
10-15 nanometers in size.59 Primary antibodies typically need to be conjugated with a 
secondary antibody for visualization. The synaptic cleft is approximately 20 nanometers,2 
so when the antibody complex is placed onto the neurotransmitter of interest and then 
targeted by a secondary antibody for visualization, this complex is typically larger than 
that of the synaptic cleft.  This will then limit the use of antibodies in providing 
information about receptor movement at the synapse. 
1.2.6 Non-Genetic Imaging Techniques 
Non-genetic imaging techniques compose a wide range of molecules that deliver 
a fluorophore to the neurotransmitter receptor of interest. This is typically done in a 
ligand-directed method that either uses a small molecule, or small peptide, as the delivery 
method.  Antibodies can also be used as a targeting method.  Since non-genetic 
techniques are partially synthetic in nature, a wide rainbow of fluorophore colors and 
properties can be made available for targeting and subsequent imaging. When designing a 
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probe for targeting of neural proteins, many factors need to be considered.  The ideal 
probe should be selective, non-toxic, water soluble, and robust enough to withstand the 
environment inside the cell if used towards intracellular targets.  Fluorophore attachment 
to either an antibody or the small molecule probe must have the above properties, and 
also be able to maintain brightness when bound to the system of interest.43b, 60 
1.2.7 Quantum Dots 
Quantum dots, QDs, are nano-sized colloid semiconductors which have 
properties that are tuned during their synthesis, and thus, can be targeted to a biomolecule 
of interest by graphing certain ligands to the surface of the QD.  This often relies on the 
interaction of biotin and streptavidin 61, acid-base interactions 62, and covalent ligand 
attachment to a polymer on the surface of the QD.63 QDs are more photostable than 
organic fluorophores and as a result, are brighter.  However, QDs are subject to blinking 
and this can lead to complications during tracking experiments. Considerations also need 
to be made with size, as QDs can vary from 2 nanometers up to 20 nanometers in size 
once fully decorated.  This would then make QDs the same size as the synaptic cleft.64 
Antibodies and QDs have been used in conjunction for long term tracking of 
proteins involved in synaptic transmission. This was demonstrated in work tracking 
glycine receptors.  Antibodies were raised against the glycine receptor and then targeted 
with a secondary biotinylated antibody.  Visualization of the receptor location in the 
soma and dendrites was then achieved by the addition of streptavidin coated QDs. 65 
Single particle tracking has been used to observe changes NMDA receptor subtypes 66, 
and in live cell imaging of AMPARs via fluorescence-recovery after photoinactivation 
experiments.67 
1.2.8 Ligand-Based Detection 
Ligands, in conjunction with other chemical entities such as fluorophores, have 
been used extensively to deliver cargo to the receptor of interest.  This can be achieved 
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through bioconjugation to the target receptor after directed targeting via a ligand that has 
been affixed with a fluorophore for visualization. The modification by the probe can 
either be covalent or non-covalent in nature. Ligand based techniques are extremely 
useful in helping to determine receptor expression in native culture.  Discoveries made by 
these techniques may be closer to what is occurring inside the brain. 
Our group 68 has designed such a probe for the detection of calcium permeable 
AMPA receptors, which is further discussed in detail in Chapter 2. Other ligand-directed 
methods for cargo delivery to neurotransmitter receptors of interest modify existing drug 
molecules to be decorated with fluorophores via a linker chain that does not interfere with 
target binding. Amy Hauck Newman and coworkers at the NIH have developed two such 
ligand-directed probes, one for the dopamine transporter (DAT) and one for the serotonin 
transporter (SERT), using this method. These probes take an analogue of an agonist for 
the particular receptor and decorated it with a fluorophore for visualization.  This then 
allows for information to be gathered about proteins synthesized inside the native 
receptor.69 The Strømgaard group at the University of Copenhagen employed a similar 
technique in the development of a NMDA receptor probe by using a NMDA antagonist 
attached to a fluorophore. Using this technique, they were able to visualize native, active 
NMDA receptors in culture.70 
1.2.9 Peptide-Based Ligand Delivery 
Much like small molecule ligand delivery, peptide-based ligand delivery has 
allowed for gains in knowledge about how receptors traffic inside the brain.  Small 
peptides can easily be synthesized thus leading to a plethora of peptide-based ligands that 
can be optimized rapidly.  A synthetic biomimetic peptide based probe was designed by 
Choquet and Imperiali to target the PDZ domains at synapse.  These domains, located on 
the postsynaptic side of the synapse, are believed to govern the general dynamics of 
receptors and ion channels to look at the dynamics of AMPA and NMDA receptors.  The 
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use of these probes provided insight into the 2-4 stoichiometry of the anchoring proteins 
of the AMPA receptor.71 As for NMDA receptors, the dynamics of the 2A and 2B 
subunits were interrogated via the PDZ biomimetic probe.  The results suggest the 
anchoring mechanism is different between the two subunits as the 2A subunit was 
blocked, but the 2B subunit was not affected. 72 
Ligand directed probes, whether small molecule or peptide based, have the 
advantage that the ligand drives the specificity of labeling towards the target. The main 
limitation of this method is that the ligand may not be as completely specific as designed 
and can have known interactions with alternate subunits on the same receptor as well as 
interactions with off-target receptors.  There are also limitations due to cell permeability 
and target location. Some probes will be difficult to deliver inside of cells, some may be 
less optimal for visualization, and some may suffer from lack of optimization. A lot of 
probes are tested in heterologous systems which lack the complexity and nuance of the 
downstream pathways which are found in the native system.  
However, small molecule probes offer advantages over genetic techniques.  The 
targeted receptors do not need to be genetically modified to contain either the FP or a 
protein tag.  Transfection of these genes cannot always be done efficiently in neurons.  
Also, the palate of fluorophores that can be used in combination with small molecule 
probes is much wider, as organic fluorophores come in a plethora of colors and 
photostablities. Small molecule probes can also be designed in a fashion that should not 
disturb the receptor of interest, something that cannot always be said of genetic 
techniques.  Due to these reasons, we decided to make small molecule probes to target 
towards AMPARs. 
1.3 Bioorthogonal Chemistry 
Bioorthogonal chemistry is any chemical reaction which occurs inside living 
biological systems, such as a cell, that does not interfere with normal biochemical 
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processes (Figure 1.9).73 This allows for the study of proteins, lipids, glycans, and other 
metabolites inside of the host system and gives an idea of how they act in real time.  
Bioorthogonal chemistry is an umbrella term which covers a wide subset of reactions 
which must have fast reaction rates and be biologically inert.  These include 1,3-dipolar 
cycloadditions (Click reactions), hydrazine/oxime formation from aldehydes and ketones, 
tetrazine ligation, isocyanide based click reactions, and quadricyclane ligations.73 
Use of bioorthogonal reagents is generally done in a two-step process.  First, the 
biological host, such as cells or living organisms, is incubated with a reporter, a 
metabolic precursor which contains a unique bioinert functional group.  Then, the host is 
treated with a probe that has a complimentary tag for bioorthogonality.  These reactions 
are second order, so the rates of reaction are dependent upon the concentrations of the 
reactants and second order reaction kinetics.73 
 
 
 
 
1.3.1 Staudinger Ligation 
The Staudinger ligation was developed by the Bertozzi lab at UC Berkley in 
2000 as a modification to the Staudinger reduction for use with azides and 
triarylphosphines.74 Strategic placement of an ester on the aryl substituent of the 
phosphate allows for the formation of an amide bond via an intermediate aza-ylide.73 
The Staudinger ligation has been particularly useful in biological imaging 
experiments as fluorophores can be incorporated.  This can be as simple as using a 
Figure 1.9: Cartoon of bioorthogonal targeting. In bioorthogonal chemistry, the cell is first 
either targeted by a probe containing a functionalized group, or fed a functionalized 
sugar (G1). This is then targeted by a reporter tag (G2) which contains either a 
fluorophore or biotin. G1 and G2 covalently bond, leaving the cell covalently tagged. 
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coumarin for the aryl ring 75 or installing a FRET quencher into the ester group.  When 
cleaved, the quencher can provide an alternate way for activation of fluorescence.76 
The Staudinger ligation does have some issues with biocompatibility as azides 
and phosphines have reactivity towards both thiols and disulfides.  This can be mitigated 
slightly by using TCEP, tris (2-carboxyethyl) phosphine, to reduce disulfides on the 
surface of the protein.77 The Staudinger ligation suffers from slow reaction kinetics, and, 
thus, excess amounts of triarylphosphine are needed to have the reaction go to 
completion, causing issues when studying sensitive biological systems.78 
1.3.2 Click Chemistry 
The application of click chemistry in biology has been revolutionary in 
determining the functions of different biomolecules that are not accessible by standard 
antibody and genetic methods.  Click reactions are those which are selective, high 
yielding, have preferable reaction kinetics, simple to preform, and can be conducted in 
benign solvents such as water.  The term “click chemistry” was coined by Sharpless in 
reference to the development of the copper-catalyzed [3+2] cycloaddition of an azide to 
an acylic alkyne.79  Sharpless did not come up with the [3+2] cycloaddition, only 
improved upon the chemistry that was discovered in the 1960’s by Huisgen.80 As such, 
terminal azides have become the most popular functional group to add for 
bioorthogonality as they are small in size and inert towards endogenous biological 
functionalities. 
Copper catalyzed click chemistry works well in most biological circumstances, 
unless cell viability is needed.  Copper is extremely toxic to living cells so there is a need 
for copper free methods that retain the same fast reaction kinetics that are needed inside 
the cellular environment.  The Bertozzi lab has, once again, been one of the pioneering 
labs in developing this technology by using molecules which contain a large amount of 
ring strain, specifically cyclooctenes.  Borrowing from president set by Huisgen 81, 
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Wittig, and Krebol 82, Bertozzi used the information that cyclooctenes react explosively 
with phenylazides and sought to lower the LUMO of the alkyne by withdrawing electron 
density away from the triple bond. 83 Bertozzi’s group went on to synthesize difluronated 
cylcooctene (DIFO), which has reaction kinetics similar to that of the copper catalyzed 
click chemistry.  Fluorophore functionalized versions of DIFO have since been 
synthesized which allows for live imaging in cells, C.elegans, and zebrafish without the 
worry of the toxic effects of copper.84 
1.3.3 Activity Based Protein Profiling (ABPP) 
One key development in the identification of protein interactions has been the 
discovery and use of activity based protein profiling (ABPP). ABPP is used to visualize 
the active form of any enzyme or protein by using chemical probes to tag it.  The 
prototype was first described in 1961 using a radioactive probe against esterases.85 This 
technique was then refined by the Cravatt group at Scripts for use with enzymes using a 
directed small molecule probe.86 Probes are directed towards an active site residue for 
covalent attachment and then visualization can be achieved.  These probes can be used to 
detect proteins in a variety of complex biological environments including cell culture, 
cell lysates, and even living cells.87 
A typical activity based probe contains three parts: a targeted reactive group, or 
warhead, a recognition element for selectivity, and some sort of detectable reagent.  The 
warhead is typically an electrophilic moiety that is used for covalent attachment to the 
protein of interest.  This electrophilic element needs to be reactive enough to quickly bind 
to the protein of interest, yet should not be able to interact with offsite proteins.  The 
recognition element acts to direct the warhead to a willing nucleophile on the surface of 
the protein.  It also serves to be selective towards the targeted protein.  The recognition 
element is typically either a fluorophore, an affinity based tag, such as biotin, resin for 
solid phase mass spec analysis, or some combination of all three. 87 
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1.4 Conclusions 
  Taking everything into account that was presented in the introduction, it is clear 
that what is sorely lacking is a small-molecule probe which can target towards, and 
identify, calcium permeable AMPARs in situ.  Use of this type of probe would allow for 
identification of calcium permeable AMPARs in different neuronal subtypes and answer 
questions about their inclusions during LTP.  To do so, we need to design a probe that is 
both specific and able to be used in a variety of cellular environments. We also need to be 
able to incorporate a reporter tag, such as a fluorophore, so we can visualize the motion 
of the AMPAR as it moves along the dendrite.  This could have implications on how 
signaling in LTP occurs through calcium permeable AMPARs and how calcium 
permeable AMPARs are trafficked to the surface.  This probe could also fill in some of 
the gaps in LTP, such as AMPAR recycling. 
  A probe towards calcium permeable AMPARs could also lead to a better 
understanding of why neurons switch between calcium-impermeable AMPARs and 
calcium permeable AMPARs after traumatic brain events, such as ischemia, or 
chemically induced trauma, such as addiction. If we are able to have a better grasp of 
what is occurring, then better and more targeted treatments could be developed. 
  To do so, we designed nanoprobe 1 as a functionalized probe for the detection of 
calcium permeable AMPARs.  Subsequent testing with nanoprobe 1 showed that 
nanoprobe 1is directed towards glutamate receptors, however we are not able to answer 
questions about subtype.  Nanoprobe 2 was then designed to more closely resemble the 
natural polyamine antagonists of calcium permeable AMPARs, specifically 
philanthotoxin-433.  Nanoprobe 2 also could be used in a more refined method to answer 
questions about subtype inclusion through pull-down experiments. However, nanoprobe 
2 was not able to bind to any receptors.  We then designed nanoprobe 3 off of the same 
scaffold and added a more promiscuous electrophile, which could be activated using 
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photochemistry.  Ultimately, the same result was seen as with nanoprobe 2.  We then 
moved into new methods for bioorthogonal chemistry by using a two-step delivery 
system.  This new method does not rely on incorporation of an azide into the protein of 
interest and will ultimately be further tested for ligand directed experiments.  
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CHAPTER 1  
NANOPROBE 1 AS A NEW METHOD FOR VISUALIZATION OF GLUTAMATE 
RECEPTORS ON LIVE TARGETS 
Portions of this chapter have been published as Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp. 
7151-62 and Combs-Bachmann, R.E., et al. J. Neurochem. 2015 133(3), pp.320-29. 
 
2.1 Introduction 
  AMPARs are the crucial glutamatergic neurotransmitters that are involved in 
memory formation. They are discussed in detail in Section 1.1.8. In brief, they are 
composed as tetrameric assemblies of GluA1-A4 subunits. AMPARs are calcium 
permeable if they either lack the GluA2 subunit or contain an unedited form of GluA2.1 
GluA2 undergoes a post-natal single RNA codon at what has been termed the Q/R site. 
Here, the encoded glutamine is changed to an arginine via action of the enzyme ADAR. 
(More about how this is exactly accomplished can be found in Section 1.1.9.) It is this 
key change that mediates calcium permeability in AMPARs. Calcium permeable 
AMPARs have very recently been shown to have a larger impact upon neuronal 
development and in certain neuropathological diseases, such as ischemic injury and 
ALS.2  Though the importance of calcium permeable AMPARs has been demonstrated, 
methods to understand their exact abundance, expression patterns, and movements are 
lacking. 
  In live neurons, methods to track these receptors, and other proteins, have 
involved the delivery of a contrast agent to the receptor as either a small molecule 
fluorophore or as a proteinaceous fluorophore. Proteinaceous fluorophores involve the 
expression of either a fluorescent fusion protein or a small protein tag that is then targeted 
by a fluorescent antibody.3 While these methods are exquisitely specific, they involve the 
genetic manipulation of the receptor of interest or the delivery of a large protein to the 
synaptic cleft.  Genetic manipulation of iGluR subunits leads to formation of non-native 
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homotetramers, due to the overexpression of the fluorescently encoded subunit. These 
non-native homomers do not provide information about movement of the native system.3b 
The synaptic cleft, or the space between the presynaptic and postsynaptic side of the two 
neurons, is only about 20 nm in size.4 The application of an antibody to the synaptic cleft 
targeted to the produced protein tag introduces a contrast agent that is similar in size to 
the synaptic cleft, thus, will again not provide much useful information about trafficking 
of the particular receptor of interest.5 
 
 
 
 
Taking the above into account, we decided to use the approach of delivering a 
small molecule probe to covalently tag our receptor of interest. In order to have an 
effective molecule for tagging native neuronal receptors, we must have a probe which is 
small, non-perturbing, and will provide a contrast agent (in this case a fluorophore) for 
visualization of the receptor. At its simplest, our probe design contains a photolabile core, 
a targeting ligand, an electrophile for bioconjugation, and a fluorophore for visualization. 
After probe application when we apply UV light to the system, the photolabile core is 
Figure 2.1: Structure of nanoprobe 1. Nanoprobe 1 which contains spermine, an 
open ion channel blocker (blue) as the targeting ligand, a ANI core (pink) 
for photolysis, an acrylamide electrophile for bioconjugation to the 
surface of the protein (red), and a Cy-3 fluorophore (green) for 
visualization. 
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cleaved, removing the targeting ligand, thus leaving behind our receptor tagged with our 
fluorophore for visualization via epifluorescence microscopy or confocal microscopy 
(Figure 2.2). The probe needs to add the electrophile in a non-perturbing manor, so that 
the receptor can function normally in order to fully understand how the receptor is 
trafficking in a condition which leads to memory formation, such as LTP.  In our first 
version of this probe, termed nanoprobe 1, we used alkoxynitroindoline (ANI) caged 
glutamate as our core, spermine as our targeting ligand, acrylamide as our electrophile, 
and Cy-3 as our fluorophore.(Figure 2.1) 6 We chose spermine as our targeting ligand for 
its known affinity for ionotropic glutamate receptors lacking GluA2 subunit, thus making 
a good candidate for the detection of calcium permeable AMPARs due to its well 
characterized use-dependency (discussed in Section 1.1.11).7 
 
 
 
 
Tethered ligands have been used as a successful method of enhancing the local 
reactivity of an electrophile proximal to a good nucleophile.  This is due to the effective 
local  rise in concentration that comes after targeting ligand binds to its binding site, and 
Figure 2.2: Cartoon of nanoprobe 1 mechanism. Glutamate (yellow dot) opens the 
ion channel and is targeted by our spermine ligand (blue key) which allows 
the acrylamide electrophile (red hook) to bind to nucleophile on the surface 
of the receptor. Photolysis with UV light breaks the ANI core (pink box) 
leaving the receptor tagged with the Cy-3 fluorophore (green star). 
Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp. 7151-62 
with permission from The Royal Society of Chemistry. 
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then places the electrophile in proximity with a nucleophile on the surface of the protein 
that is capable to undergo a Michael addition, such as a cysteine, serine, lysine, threonine, 
or tyrosine.  The effective concentration of the nucleophile rises approximately 100-1000 
fold locally in the small space where the electrophile is captive in.6, 8 
2.2 Results 
2.2.1 Patch-Clamp Electrophysiology Confirms Use-Dependence of the Probe 
 
 
 
 
 
 
Figure 2.3: Patch-clamp electrophysiology results from nanoprobe 1. A) Evoked glutamate 
currents in HEK 293T cells transfected with GluA1 (L497Y)-pIRES2-eGFP. The evoked 
current was taken first with 20 µM glutamate. Cells were incubated with 20 µM glutamate 
and 1 µM nanoprobe 1 for 1 min and then the evoked current was re-measured. UV light 
and glutamate were co-applied and the current was measured. A 60% blockage of current 
was observed. The cells were washed for 1 min and the evoked glutamate current was 
measured again, showing a return to the basal current. B) The same experiment was in A 
was performed without the co-incubation with 20 µM glutamate. A slight block in the 
evoked glutamate current was observed (~20%) without the co-incubation of glutamate 
and nanoprobe 1. C) Quantification of the evoked glutamate current before and after UV 
photolysis of the ANI core with co-incubation of glutamate (n=10) and without the co-
incubation of glutamate (n=6). Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011, 
9, pp. 7151-62 with permission from The Royal Society of Chemistry. 
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To confirm the use-dependence of the probe, we used patch-clamp 
electrophysiology to measure the block of current evoked by applied glutamate and 
adding in nanoprobe 1. AMPARs display an inwardly rectifying current and this is lost 
upon biding of polyamines to the receptor. This loss of the current is also one of the key 
ways to determine if the receptor is calcium permeable or calcium impermeable, as 
calcium impermeable AMPARs are not sensitive to blocks by polyamine ligands; thus do 
not exhibit current loss.9 We transiently transfected HEK-293T cells with GluA1 
(L497Y)-pIRES2-eGFP homomultimers to create calcium permeable receptors in a 
heterologous system. We then co-applied 20 µM glutamate with nanoprobe 1 and 
measured the glutamate evoked current. The current decreased by approximately 60% to 
that of an initial pulse of glutamate. This is consistent with data that has been collected by 
others using other synthetic polyamines such as napthylacetylspermine (NAS).10 We then 
applied UV light (380 nm) to the system to uncage the photolabile ANI core and applied 
constant pulses of glutamate and we found that the evoked current returned back to 
baseline glutamatergic signal. These experiments were repeated using 1µM nanoprobe 1 
alone. What is found is there is only a slight blockage of the channel (~20%) and that 
there was no UV-dependence on release of the spermine ligand.  The slight pore blockage 
may be due to the stochastic nature of AMPA receptors to open in the presentence of the 
applied voltage.6, 10 This finding is graphically demonstrated in Figure 2.3. 
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2.2.2 Live Cell Imaging of Dissociated Cultures of Hippocampal Neurons with Nanoprobe 1 
Using Epifluorescence Microscopy 
  Next, we investigated the targeting capability of nanoprobe 1 towards 
synaptically-active, polyamine-sensitive glutamate receptors in primary dissociated 
hippocampal cell culture. Dissociated cultures of rat hippocampal neurons were prepared 
and incubated to day in vitro (DIV) 20- 24.  Neurons were first imaged using transmitted 
light in order to determine areas were synaptically active neurons should reside. They 
were then serially imaged using fluorescent light to acquire background data. Neurons 
were then bathed with either spermine ligand lacking nanoprobe (where a carboxylic acid 
is in place of the amide attached ligand) or nanoprobe 1 for 2 minutes in total darkness to 
prevent premature photolysis of the ANI core. UV light (380 nm) was then applied to the 
system and serial fluorescent imaging was then resumed.  Extracellular buffer solution 
was constantly perfused across the system throughout the experiment, with the exception 
of the application of ligand lacking nanoprobe and nanoprobe 1. The Cy-3 fluorescence 
that is observed is due to receptors being labeled in a use-dependent fashion with 
nanoprobe 1. Fluorescence accumulation appears to be occurring in areas located at 
synaptic regions, which is where active glutamatergic receptors are known to reside. We 
can see from the bright-field image that these areas appear to contain synaptic spines, 
which is where any synaptic activity would occur. (Figure 2.4) 6 
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When the ligand lacking probe is applied to the system, there is a slight increase 
in fluorescence. This fluorescence is not persistent as it is quickly washed away when 
perfusion is resumed. However, when nanoprobe 1 is applied to the same system, there is 
persistence to the fluorescence accumulation that remains through the imaging event.  
These results taken together suggest that nanoprobe 1 is acting in a ligand-dependent 
manner and that we are achieving covalent attachment of the probe through a Michael 
addition of the acrylamide to the biological nucleophile on the receptor surface.6 
Figure 2.4: Representative images of neurons labeled with nanoprobe 1. A) Transmitted light 
image of a neuron B) Fluorescence image of a neuron labeled with 750 nM of non-
liganded nanoprobe 1 C) Fluorescence image of a neuron labeled with 750 nM nanoprobe 
1 D) Time course of five ROIs (regions of interest) along a dendrite. The areas pointed out 
with the arrows are 1 min after non-liganded nanoprobe and nanoprobe 1 application .E) 
Fluorescence time course of the five ROIs (from D) during the course of the imaging 
experiment displaying the prolonged fluorescence after the liganded application of the 
probe. Reproduced from Vytla, D. et al. Org.Biomol. Chem. 2011, 9, pp. 7151-62 with 
permission from The Royal Society of Chemistry. 
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2.2.3 Live Cell of Dissociated Cultures of Hippocampal Neurons with Nanoprobe 1 Using 
Confocal Microscopy 
  We then wanted to further investigate the efficacy of our probe on neurons.  We 
first examined the dose dependency of our probe to find the optimal, minimal 
concentration that can be used. Dissociated cultures of rat hippocampal neurons were 
grown to DIV 14-17, as this is reported to be when cultured neurons are found to be 
expressing synaptically active AMPARs.11 We explored a concentration range from 100 
nM, 300 nM, 1 µM, and 3 µM of nanoprobe 1 to determine the lowest concentration that 
would give us the best fluorescence accumulation. Imaging took place similar to that of 
the epifluorescence imaging, with the major difference being the lack of constant 
perfusion of fresh extracellular recording buffer being flowed across the neurons due to 
technical limitations of the confocal microscope. Coverslips of neurons were removed 
from their home media and washed three times with extracellular recording solution. 
They were then imaged to collect the background fluorescence and then incubated with 
20 µM glutamate along with the various concentrations of nanoprobe 1 in extracellular 
buffer for 5 minutes in total darkness to prevent premature photolysis of the ANI core. 
UV light was then applied to the system, and the coverslip was washed three times with 
extracellular buffer. Neurons were then imaged to determine the fluorescence 
accumulation on the cells. The same coverslip of neurons were used for each 
concentration range to best determine the dose dependence of nanoprobe 1.11b 
  
 
44 
 
 
 
 
We found that our lowest concentration, 100 nM, did not provide significant 
fluorescence over the background.  However, the next highest concentration, 300 nM, 
resulted in a marked increase of fluorescence over background and in areas that we had 
seen in our epifluorescence imaging experiments. The brightest areas appeared to be on 
that of synaptic spines, which was confirmed by examining the bright-field morphology. 
(Figure 2.5) When the concentrations were increased to 1 µM and 3µM, the fluorescence 
density at the areas described above was increased, but also increased amounts of non-
specific labeling of other structures. We determined that for all further imaging 
experiments incubations of 20µM glutamate with 300 nM nanoprobe 1 would give us the 
best fluorescence density with the lowest background.11b 
Figure 2.5: Fluorescence accumulation with increasing amounts of nanoprobe 1.  
Nanoprobe 1 was incubated with DIV 14-17 neurons along with 20µM glutamate. 
Nanoprobe1 was used at 100 nM, 300 nM, 1µM, and 3µM to determine the lowest 
working concentration to be used on cells with minimal background. The bar graph 
quantifies fluorescence accumulation. Representative images are shown underneath. 
Reproduced from Combs-Bachmann, R.E., et al. J. Neurochem. 2015 133(3), 
pp.320-29with permission from John Wiley and Sons. 
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2.2.4 Competition Experiments of Nanoprobe 1 with Napthylacetylspermine and DNQX 
   We next wanted to determine the specificity of nanoprobe 1 against known 
AMPAR antagonists.  We chose napthylacetylspermine (NAS) and 6,7-
dinitroquinoxaline-2,3-dione (DNQX) as our antagonists. Nanoprobe 1 was designed to 
act like NAS, so NAS was chosen to determine if the fluorescence we are seeing is due to 
off-target reactions of nanoprobe 1 or if it is targeting the same channels as NAS. As 
mentioned in the Section 1.1.9, NAS is used as a specific targeting moiety of calcium 
permeable AMPARs and KARs over NMDARs.10 DNQX was chosen due it is known 
activity to block the glutamate binding site on AMPARs and KARs, preventing the ion 
channel from opening.  
 
 
 
 
Figure 2.6: Dose-dependent labeling of nanoprobe 1 in competition with NAS and DNQX. 
Nanoprobe 1 (300 nM) was dosed in competition with NAS (300 nM) or DNQX 
(10µM). Fluorescence activity (shown in bar graphs) was decreased in the presence 
of the antagonist and regained after subsequent dosing with nanoprobe 1. 
Fluorescence was normalized to maximal accumulation. Representative images are 
shown beneath bar graph. Reproduced from Combs-Bachmann, R.E., et al. J. 
Neurochem. 2015 133(3), pp.320-29with permission from John Wiley and Sons. 
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For our NAS experiments, dissociated cultures of rat hippocampal neurons were 
grown to DIV 14-18.  Cells were washed three times with extracellular buffer and were 
then imaged to collect background fluorescence. They were then co-incubated with 300 
nM NAS and 300 nM nanoprobe 1 in the presence of 20 µM glutamate for 5 minutes. 
Cells were then washed three times with extracellular recording buffer and had UV light 
applied to them for photolysis of the ANI cage. Fluorescent images were then collected.  
The same set of cells were then washed and bathed in 300 nM nanoprobe 1 with 20 µM 
glutamate for 5 minutes. Cells were washed three times in extracellular solution and then 
fluorescent images were collected.  Co-incubation of the neurons with NAS and 
nanoprobe 1 lead to a slight increase in fluorescence over the background, however, 
application of nanoprobe 1 alone lead to a large amount of fluorescence.  This suggests 
that NAS and nanoprobe 1 are in competition for the same binding site. (Figure 2.6) 
  For our DNQX experiments, co-applications of 10 µM DNQX and 300 nM 
nanoprobe 1 and all imaging were carried out the same as for the NAS experiments.  We 
found that co-application of DNQX and nanoprobe 1 once again has a slight increase in 
fluorescence compared to that of the background.  The application of 300 nM nanoprobe 
1 alone caused a large increase in fluorescence, suggesting that nanoprobe 1 is targeting 
neurons that are sensitive to DNQX. Taken together, the NAS and DNQX co-application 
data suggests that nanoprobe 1 is labeling neurons that may indeed be calcium permeable 
AMPARs.11b 
2.2.5 Fluorescence Gel with Nanoprobe 1 
  We wanted to confirm that we were indeed labeling calcium permeable 
AMPARs with nanoprobe 1.  To do so, we turned to SDS-PAGE analysis of nanoprobe 1 
labeled neurons.  Each AMPAR is composed of heterotetramers of GluA1-GluA4 
subunits; the weight of each is ~ 100 kDa.  Also, the density of AMPARs is varied across 
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brain regions and neuronal subtypes.  Knowing this, we chose to label the cortex, the 
midbrain, and the cerebellum with two different concentrations of nanoprobe 1 in order to 
pulldown subunits that would suggest calcium permeable AMPARs are being labeled.  
Dissociated cultures of rat cortex, midbrain, and cerebellum were grown to DIV 18 in T-
flasks.  T-flasks were washed three times with extracellular buffer and then 300 nM or 
3µM nanoprobe 1 along with 20 µM glutamate were applied for 5 minutes.  Cells were 
then washed three times with extracellular solution and lysed with a probe sonicator. The 
cell lysates were then spun down and the cell pellet was re-suspended in PBS. The cell 
lysates were separated on a 10% SDS-PAGE gel and fluorescence was measured using a 
Typhoon gel scanner.  Western blots were first run against a pan-AMPA antibody to 
confirm that ionotropic glutamate subunits were present, then against GluA1 and GluA2 
antibodies.  
 
 
 
 
 
Figure 2.7: Fluorescence gel of nanoprobe 1 labeled neuronal proteins. 
Cortex, mid-brain, and cerebellar neurons were grown to they were 
synaptically active. Neurons were labeled with either 300 nM or 3 
µM nanoprobe 1, lysed, and the proteins were separated on a 10% 
SDS-PAGE gel.  Fluorescence bands were measured using a 
Typhoon 9210 flatbed imager. Fluorescence bands were measured at 
the desired 100 kDa band, as well as 180, 85, 80, 60, 50, and 45 kDa. 
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Our gel results show that we are indeed labeling a band that is around 100 kDa, 
as well as many other bands (Figure 2.7).We are also labeling targets which are at 180, 
85, 80, 60, 50, and 45 kDa. Nanoprobe 1 is based upon a class of polyamine toxins that 
have been shown to display antagonism towards AMPARs, but there are other polyamine 
sensitive targets, specifically acetylcholine receptors and KARs, that are be present in 
primary culture. We cannot say if these are specific targets of the probe, or are just targets 
which are reactive to the acrylamide electrophile on nanoprobe 1.  
2.3 Discussion 
  Using a heterologous system of HEK 293T cells transfected with GluA1 L497Y 
homomers and patch-clamp electrophysiology, we were able to determine that our probe 
was indeed acting in a use-dependent fashion. Polyamine toxins have been used to target 
towards active calcium permeable AMPARs as they will block the glutamate evoked 
current that travels through the ion pore. This has been found with natural polyamine 
toxins, such as Joro spider toxin and argiotoxin,9b, 12 as well as synthetic polyamines, such 
as NAS.10 The IC50 of NAS is 0.33µM and blockage of calcium permeable AMPARs is 
around 70%.10 This places our probe on par with NAS, however the IC50 of nanoprobe 1 
would be extremely challenging, if not impossible, to determine as nanoprobe 1 does not 
have a detectable off-rate. 
  In our initial imaging experiments, we targeted our probe to areas of known 
pathology where synaptically-active, polyamine-sensitive glutamatergic neurons are 
known to reside in dissociated cultures of rat hippocampal neurons. The distribution of 
these receptors is heterologous between cultures and contains many other neuronal 
receptor subtypes, specifically acetylcholine receptors. Our cultures also contain a very 
large number of biological nucleophiles that could be potentially targeted by nanoprobe 
1.  Thus it is not impossible to imagine that we should have a large amount of 
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background reactivity of the probe towards these nucleophiles. However, nanoprobe 1 is 
not just the acrylamide electrophile, rather a molecule that contains acrylamide as part of 
its structure.  Labeling of the targeted protein is only occurring once the effective 
concentration of the probe and the acrylamide is achieved. This is clearly seen when 
neurons are labeled with spermine lacking nanoprobe. We do not observe a large 
accumulation of fluorescence anywhere, which would be expected if acrylamide was 
having a large amount of off-target labeling.6   
  Our cultures also do not only contain active AMPARs, rather active glutamate 
receptors. This means that we have both NMDARs and KARs present in culture. It is 
possible that we are labeling both of these receptor subtypes as we are using a high 
concentration of probe in our initial imaging experiments. Spermine can have activity 
against NMDARs,13 however, much like how our probe is not simply acrylamide, our 
probe is not simply spermine. Nanoprobe 1 was designed to resemble NAS, and NAS has 
been used as a specific target towards calcium permeable AMPARs over NMDARs.10 We 
can say that nanoprobe 1 is sensitive to non-NMDAR polyamine-sensitive glutamatergic 
receptors. 
  Confocal imaging data of neurons labeled with nanoprobe 1 furthered our 
understanding of where nanoprobe 1 is targeting.  We first determined the lowest 
concentration that we could use in imaging experiments in order to limit off-target 
effects.  The IC50 of polyamine toxins varies, but ranges from ~ 10 nM to 15 µM 
depending on its intended target.14 Our probe falls into this scale, as 300 nM gave us the 
best contrast. Once determined, our next goal was to determine the specificity of 
nanoprobe 1.  By using known AMPAR antagonists NAS and DNQX, we examined the 
competition of nanoprobe 1 against them. What we found is that co-incubation with NAS 
or DNQX prevents nanoprobe 1 binding, which is regained when nanoprobe 1 is 
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reapplied alone. This suggests that nanoprobe 1 is indeed targeting towards receptors that 
would appear to be calcium permeable AMPARs. 
  We then wanted to determine which receptors we were truly targeting.  This was 
done via SDS-PAGE analysis of three different regions of neurons labeled with 
nanoprobe 1. What we found is that there is labeling something that could be an AMPAR 
subunit, along with a variety of other unintended targets.  This is certainly due to our 
polyamine targeting ligand on nanoprobe 1, spermine, directing towards other polyamine 
sensitive receptors, chiefly acetylcholine receptors. Our cultures come from a primary rat 
source and contain a wide variety of receptor subtypes. These subtypes vary not only in 
where they are located in the brain, but also from culture to culture. However, not all of 
these receptors will be blocked by both NAS and DNQX as our imaging experiments 
clearly show.  Literature widely reports that both NAS and DNQX are antagonists 
towards calcium permeable AMPARs, but they could not be as selective as reported.  
Most of the early work in the literature is done in heterologous cultures in which 
AMPAR subunits are present in high concentrations.  There could very well be other 
targets in neuronal culture that are polyamine sensitive that are yet to be identified.  In 
conclusion, nanoprobe 1 is a useful tool for the detection of active glutamate receptors in 
dissociated culture of rat neurons, but questions about subtype inclusion in these tagged 
receptors still need to be addressed.  
2.4 Methods 
2.4.1 HEK 293T Cell Culture 
  Cells were grown to they were 70 % confluent on cover glass (12mm, 1.0 size) in 
DMEM media containing 10% FBS. Cells were grown at 6 % CO2 at 37°C. Cells were 
transfected using LipoD293 (SignaGen Laboratories, Gaithersburg, MD, USA) with 
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bicistronic vector GluA1 (L497Y)-pIRES2-eGFP 15 1-3 days before electrophysiological 
experiments.  
2.4.2 Dissociated Hippocampal Cell Culture 
  Primary dissociated hippocampal cell cultures were prepared from embryonic 
day E18-20 Sprague-Dawley rat embryos and were cultured on polylysine-coated 
coverglass (25.5 mm, 1.0 size for epifluorescence microscopy; 12mm 1.0 size for 
confocal microscopy) in serum containing media identical to previous reports.16 Cells 
were grown in 5% CO2 and at 37°C. All animal care and experimental protocols were 
approved by the Animal Care and Use Committee at University of Massachusetts, 
Amherst, Amherst, MA, USA. 
2.4.3 Dissociated Cortex, Midbrain, and Cerebellar Cell Culture 
  Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared 
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2 
T-Flasks coated in poly-lysine in serum containing media identical to previous reports.16 
Cerebellar culture media was supplemented with 1M potassium chloride (1mL in 50 
mL).17 Cells were grown in 5% CO2 and at 37°C. All animal care and experimental 
protocols were approved by the Animal Care and Use Committee at University of 
Massachusetts, Amherst, Amherst, MA, USA. 
2.4.4 Live Cell Imaging with Nanoprobe 1 Using Epifluorescence Microscopy 
  Hippocampal neurons were imaged by excitation with a light from a Sutter 
Lambda-LS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti 
series microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA oil 
objective lens (Nikon) was employed for all imaging epifluorescence experiments. The 
Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and 575 
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ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images were 
acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City, Japan) 
and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA). 
  Cells were mounted in a 25 mm perfusion apparatus (ALA M-525, ALA 
Scientific, Farmingdale, NY, USA) and bathed in extracellular buffer solution containing 
138 mM NaCl, 1.5 mM KCl, 1.2 mM MgCl2, 5 mM HEPES, 2.5 mM CaCl2, and 14 mM 
glucose at pH 7.4. Fresh recording buffer was constantly perfused over hippocampal 
cultures using a perfusion device (ALA-UM8, ALA Scientific) at all times except for 
nanoprobe 1 or ligand lacking nanoprobe were incubated.  Fluorescence images were 
acquired at 20 frames per second using the Cy-3 filter set to capture background and 
post-labeled stopped leaving minimal buffer on cells. Next, 200 µL of 750 nM ligand 
lacking nanoprobe was added to the bath and incubated for 2 minutes. Perfusion was 
restarted and imaging was carried out for 10 minutes at which point the background 
fluorescence was re-established and measured again for 1 minute. Perfusion was again 
stopped, leaving minimal buffer on the cells.  Finally, 200 µL of 750 nM nanoprobe 1 
was added to the bath and incubated for 2 minutes. Perfusion was reinstated and imaging 
was carried out for 10 minutes. 
2.4.5 Image Analysis of Epifluorescence Imaging Data 
  Images were analyzed using ImageJ (U.S. National Institutes of Health, 
Bethesda, MD, USA).  Fluorescence was quantified using ROI (region of interest) 
analysis of multiple regions placed over putative synaptic sites and areas of background. 
The mean fluorescence intensity was background subtracted and normalized to the 
measured fluorescence at 1 minute before the application of ligand lacking nanoprobe 
and time courses were plotted using GraphPad Prism (La Jolla, CA, USA).  Seven image 
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series were analyzed and the data combined for a total of 131 ROIs analyzed.  GraphPad 
Prism was used to plot the data.  
2.4.6 Live Cell Imaging with Nanoprobe 1 Using Confocal Microscopy 
  Hippocampal neurons were imaged using a Nikon TiE microscope fitted with a 
CSU-x1 Yokogawa spinning disk confocal scan head (PerkinElmer, Waltham, MA, 
USA) and an Andor iXon+ electron-multiplying CCD camera (Andor, Belfast, Northern 
Ireland).  All confocal settings were kept the same for the labeling experiments.  The 
microscope and lasers were controlled by MetaMorph software (Molecular Devices, 
Sunnyvale, CA, USA).  A 100x 1.4 NA objective (Nikon) was used for imaging. 250 ms 
exposures of a 561 nm laser were used to image all fluorescence images, keeping 
everything below pixel saturation.  Pixel size is a 140 x 140 nm square. 
  Coverslips containing neurons were removed from their home media and 
mounted into a 12 mm perfusion apparatus (Warner Instruments, P-3, RC-25, Warner 
Instruments LLC, Hamden, CT, USA) and were bathed in extracellular recording buffer.  
Coverslips were then washed three times and placed in a static bath of extracellular 
solution. They were then imaged for 2 minutes to establish background fluorescence 
levels.  Testing solutions were then applied, either 20 µM glutamate with the ranging 
nanoprobe 1 concentration, or the co-application of nanoprobe 1 with 10µM DNQX 
(Tocris Bioscience, Bristol, United Kingdom) or 300 nM NAS (Sigma Aldrich St. Louis, 
MO, USA), for 5 minutes in total darkness. Coverslips were irradiated with 405 nm light 
for 15 seconds for photolysis of the ANI core. Coverslips were then washed three times 
with extracellular solution and returned to a static bath.  Imaging was then resumed. 
2.4.7 Image Analysis of Confocal Imaging Data 
  All images were analyzed using ImageJ.  To quantify fluorescence accumulation 
of nanoprobe 1, areas of the field of view in which there was fluorescence activity after 
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application of glutamate and nanoprobe 1 were identified by using the Triangle threshold, 
in which the maximum of the histogram along a data linear data range is used as the 
maximum threshold value.18 These threshold values were then used to generate a massive 
ROI list of all labeled regions in the field.  ROIs were then used at all previous time 
points for quantification during the dosage and competition experiments.  Fluorescence 
intensities were quantified using the mean grey value of regions labeled with nanoprobe 1 
and then background subtracted from the average of three ROIs drawn in areas where no 
cells were present in the corresponding brightfield image.  All brightness and contrast 
was set equal in groups of comparative images for analysis.  Group mean values at each 
dosage or competition experiment were compared to the respective control values using a 
one-way nonparameteric Kruskal-Wallis test.  Significance values were assigned using a 
Dunn’s multiple comparison test. In all cases, significance was determined to be p < 0.05 
and p values are reported in all cases.  Asterisks signify statically significance.  
2.4.8 Fluorescent SDS-PAGE gel of nanoprobe 1 labeled neurons 
  25 cm2 T-Flasks were washed three times with extracellular buffer. 7 mL of 300 
nM or 3 µM solutions of nanoprobe 1 in extracellular buffer with 20 µM glutamate were 
added into the flasks and allowed to sit for 5 minutes at room temperature. Flasks were 
then washed again three times with extracellular buffer. 2 mL of lysis solution, 1x PIC in 
1x PBS buffer, were added to each flask and cells were then scraped into a 2 ml 
Eppendorf tube.  The cell lysates were then sonicated with a probe sonicator at 30% 
power for 1 minute. A bicinchoninic acid (BCA) assay was run to ensure that same 
amount of protein was added to each lane. Samples were run on a 10% SDS-PAGE gel 
and sat for 16 hours in 10% acetic acid solution.  The gel was imaged using a Typhoon 
9210 flatbed imager using 532 laser line set using a 588 bandpass filter.  
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2.4.9 Western Blots of Nanoprobe 1 Labeled Neurons 
  Using the same samples as the fluorescence gels and a BCA assay was run prior 
to each blot.  Protein lysate samples were run on 10% SDS-PAGE gels and transferred to 
a nitrocellulose membrane using CAPS buffer for 16 hours at 4°C.  Blots were first 
probed with 1:200 Pan-AMPA (GluR-1/2/3/4) rabbit polyclonal antibody (Santa Cruz 
Biotechnology Inc. Dallas, TX, USA).  Subsequent blots were probed for GluA1 
(Millipore, Billerica, MA, USA) and GluA2 (Millipore).  
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CHAPTER 2 
PHILANTHOTOXIN BASED PROBE FOR THE DETECTION OF CALCIUM 
PERMEABLE AMPA RECEPTORS 
3.1 Introduction 
  From our prior studies with nanoprobe 1, it is clear that we need to develop a 
probe that could identify the proteins we were targeting. We also wanted to develop a 
probe that could be easily synthesized and be used with a wide number of applications for 
probing our receptors of interest. There are a wide number of polyamine toxins (Figure 
1.7) that are used and modified to be used study calcium permeable AMPARs. Looking 
at each of the polyamine toxins, the two main moeites of each are the aromatic head 
group and the polyamine tail.  We selected philanthotoxin-433 to move forward with as a 
potential new probe for the detection of calcium permeable AMPARs for a number of 
reasons, including its selectivity towards calcium permeable AMPARs and the ease of 
modification.   
  Philanthotoxin-433 is the toxin in the venom of the parasitic wasp, Philanthus 
triangulum, or the Egyptian digger wasp (also known as the European bee wolf).  This 
solitary wasp is generally an herbivore, but the pregnant wasp uses its venom to paralyze 
its prey, honeybees, to leave for the larvae to eat.1 The venom of P. triangulum was show 
by Piek and colleagues to be an antagonist of glutamatergic synapses in the motor 
neurons of both locus leg muscle and honeybee muscle junctions.2  In 1988, 
philanthotoxin was isolated from the venom via HPLC, its structure was determined, and 
then pure toxin was synthesized. This molecule was named phlianthotoxin-433, with the 
numbering referring to the number of methylene units contained in the polyamine tail.1 
Derivatives of phlianthotoxin have since been synthesized, aiming to increase the 
efficacy over the first isolated compound.3 
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  Nanoprobe 2 modifies philanthotoxin so that we can use it as a probe for the 
detection of calcium permeable AMPARs.  To do so, we added an electrophile for 
bioconjugation onto the surface of the protein.  We also installed an alkyne handle so that 
our probe can be targeted and visualized with azido functionalized reporter tags that can 
be attached using a 1,3-dipolar cycloaddition, or a click reaction.  
We redesigned our nanoprobe to allow us to determine which receptors our probe 
was targeting. One of the key reasons that we installed an alkyne handle onto nanoprobe 
2, was to use our new probe in activity-based protein profiling experiments.  Chemical 
activity based protein profiling (described in Section 1.3.3 (chem ABPP)) was refined by 
Benjamin Cravatt’s group, and involves a small molecule probe, equipped with an 
alkyne, being directed towards a target of interest.  Once the probe is covalently attached, 
the protein can then be visualized using an azide functionalized reporter tag, usually a 
fluorophore or biotin.4 The output can be visualized via SDS-PAGE analysis. Any bands 
that are marked by the reporter tag can then be further analyzed by mass spectrometry. 4b 
3.2 Results  
3.2.1 Design of Nanoprobe 2 
  Nanoprobe 2 was designed to retain the key features of phlianthotoxin as much 
as possible; unlike nanoprobe 1which was based on a synthetic analogue. To do so, we 
eliminated the photoreactive core in nanoprobe 1 from the probe design of nanoprobe 2. 
This was done for two main reasons.  One was for the ease of synthesis of nanoprobe 2.  
Nanoprobe 1 was completed in 26 steps, with the synthesis of the nitroindole core being a 
portion of them.  The second was to make a probe that was more representative of the 
polyamine toxin class.  We wanted to produce a probe that more closely resembled the 
natural toxin, so that some of the off-target effects we were observing with nanoprobe 1 
could be eliminated.  We also wanted a probe that was a bit easier to use in the chemical 
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ABPP experiments.  Removal of the photolabile core also eliminates the photolysis step, 
which simplifies its use. To the core structure of philanthotoxin-433, we amended the 
butyl chain so it contains an electrophile, acrylamide, for bioconjugation to the surface of 
the receptor. Much like nanoprobe 1, we are relying on proximity accelerated reactivity 
to facilitate the Michael addition of the acrylamide to a nucleophile on the surface of the 
protein. We also amended the phenolic hydroxide so that it contains an alkyne handle 
than can be used for conjugation with an azide functionalized reporter tag.  
   Synthesis of nanoprobe 2 commenced with tyrosine. We then protected the 
primary amine with Boc and the carboxylic acid with a methyl ester to install the alkyne 
handle.  Subsequent Boc deprotection allowed for the installation of n-
acrylaminohexanoic acid for the addition of the electrophile. We then deprotected the 
carboxylic acid for peptide coupling with triBoc spermine. Boc deprotection afforded 
nanoprobe 2, which contains spermine as our targeting ligand, much like nanoprobe 1. 
(Scheme 3.1) 
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3.2.2 Confocal Imaging of Cerebellar Neurons with Nanoprobe 2 
  We wanted to investigate if nanoprobe 2 was behaving similar to nanoprobe 1 in 
dissociated cultures of neurons.  We chose to use dissociated cultures of rat cerebellar 
neurons in this case due to a reported higher concentration of calcium permeable 
AMPARs.5 We first needed to make nanoprobe 2 amendable for visualization in live cell 
imaging. To do this, we clicked on a fluorescent reporter tag, fluorescein (FAM-5) azide, 
to nanoprobe 2. Since this click reaction is done through copper catalyzed methods, it 
needed to be done prior to application to live cells to prevent the toxic effects of copper 
on the neurons.  Neuronal cultures were grown to DIV 18-20, washed three times with 
extracellular recording solution, and mounted into a perfusion apparatus.  They were then 
covered in extracellular solution and imaged to collect background fluorescence data.  
Nanoprobe 2 (10 µM) in extracellular solution was added to the neurons for 5 minutes at 
room temperature.  Neurons were then washed three times and imaged to collect 
fluorescence. 
Similar to what we observed with nanoprobe 1, nanoprobe 2 had fluorescence 
accumulation that occurred in areas around synaptic regions that were seen in the 
brightfield image.  This suggests that nanoprobe 2 is targeting areas similar to nanoprobe 
1.  The fluorescence accumulation in these areas is greater than that of the background.  
This is seen in Figure 3.2  
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3.2.3 Chemical Activity Based Protein Profiling on Dissociated Cultures of Rat Cortex, Mid-
Brain, and Cerebellar Neurons 
  We then planned to investigate which ionotropic glutamate receptor subtypes we 
are targeting with nanoprobe 2.  To do so, 25 cm2 T-flasks of cortex, mid-brain, and 
cerebellar neurons were grown to synaptically active (DIV 14-18). Flasks were washed 
three times with extracellular recording buffer and then 0, 1, 3, or 10 µM of nanoprobe 2 
dissolved in 7 mL of extracellular solution with 20 µM glutamate was applied for 5 
minutes at room temperature. Control solutions containing equal concentration of 
nanoprobe 2 and NAS were also made for additional flasks. Flasks were then washed 
Figure 3.1: Confocal imaging of cerebellar neurons with nanoprobe 2. A) Transmitted 
light image of cerebellar neurons B) Pre-probe application fluorescence image 
C) Post-probe application fluorescence image D) Graph of fluorescence 
accumulation in synaptic regions. Fluorescence is higher than the pre-probe 
application. E) Overlay of post-probe fluorescence image with white light image 
showing that fluorescence accumulation is in areas that are synaptically active. 
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three more times with extracellular solution. Next, 1 mL of lysis solution (1 x PIC, 1x 
PBS) was added to each flask and cells were scrapped to remove from sides of the T-
flask. Cells were lysed, and the membrane portions were spun down. The membrane 
pellet was lysed again and the lysates were subjected to chemical activity based protein 
profiling, chem ABPP.  In chem ABPP, the azide functionalized reporter tag is added to 
the lysate to undergo copper mediated click chemistry.  The treated lysates were then 
separated on a 10% SDS-PAGE gel.  
 
   
 
Figure 3.2: In-gel fluorescence and Western blot of rat midbrain samples 
labeled with nanoprobe 2. Top: Western blot of nanoprobe 2 labeled 
midbrain samples conjugated with biotin azide. Samples were 
separated on a 10 % SDS-PAGE gel, transferred to a nitrocellulose 
membrane, and probed using streptavidin-HRP. Bottom: In-gel 
fluorescence of nanoprobe 2 labeled midbrain samples conjugated 
with rhodamine azide. Samples were separated on 10% SDS-PAGE 
gel. In both cases, no signal was detected in probed neuronal samples. 
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We used either rhodamine azide for fluorescence visualization or biotin azide for 
Western blot analysis with streptavidin-HRP.  The dual mode of visualization allows for 
different levels of detection due to different sensitivities of each technique.  The amount 
of protein we are targeting amounts to only a very small portion of the total brain lysate. 
After running both of these gels multiple times, we do not observe any signal in lanes 
which contain brain lysate. (Figure 3.3)  
3.2.4 Chemical Activity Based Protein Profiling with Cortex and Cerebellum Samples from 
Female C57BL/6 Mice 
  After multiple trials with pre-natal dissociated culture, we then went to try 
nanoprobe 2 in adult mouse brain samples because we were concerned that there was a 
low concentration of our desired protein in our dissociated culture samples.  Brain 
samples were kindly provided by Jesse Mager’s lab in Veterinary and Animal Sciences at 
UMass, Amherst.  Brains were removed, segmented, and placed into extracellular 
solution containing 20 µM glutamate and 0, 1, or 3 µM nanoprobe 2 or solutions 
containing 20 µM glutamate with equimolar mixtures of nanoprobe 2 and NAS at the 
same concentration as above.  Brain samples were allowed to incubate in these solutions 
for 15 minutes at room temperature and were then washed three times with extracellular 
solution. Samples were then lysed using a probe sonicator and the lysates underwent 
chem ABPP with biotin azide. Lysates were separated on a 10% SDS-PAGE gel, 
transferred to a nitrocellulose membrane, and then probed using streptavidin-HRP.  The 
bands in this case were inconclusive (Figure 3.4), as biotin staining was present in control 
samples which did not have any probe present.  The cerebellum has a large amount of 
endogenous biotin present in the mouse brain, the quantity is large enough that it can be 
identified with streptavidin conjugated reporter tags.6 
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With this new information, we aliquoted 100µL of cell lysate to pre-clear with 
streptavidin beads and run the supernate through the chem ABBP process. The supernate 
was loaded onto a 10 % SDS-PAGE gel and a Western blot was done with streptavidin-
HRP.  Again, there was strong labeling for biotin in the control lanes. (Figure 3.5) This 
may be due to the amount of biotin present being higher than the capacity of the 
NeutrAvidin beads.   
 
 
Figure 3.3: Western Blot on C57BL/6 Cerebellum Samples. Cerebellum 
samples were separated on a 10% SDS-PAGE gel, transferred to 
nitrocellulose, and probed using StrepHRP (1:10000). There is strong 
biotin staining in the 0 µM control lanes. 
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3.2.5 Chemical Activity Based Protein Profiling with Neurons from Protophormia 
terraenovae 
  We decided to try a different approach in the testing of nanoprobe 2. Since 
nanoprobe 2 is based on an AMPA receptor antagonist that has known activity in insects, 
we decided to try to see if we could pull down targeted receptors in Protophormia 
terraenovae, or the northern blowfly, (also known as the blue-bottle fly). (Gift from Dr. 
John G. Stoffolano Jr., UMass, Amherst Plant, Soil, and Insect Science.)  Flies were 
anesthetized with chloroform and injected with 10 µL of 30µM nanoprobe 2. This 
concentration is similar to that used in the locus and honeybee experiments performed by 
Piek.2 Flies appeared to be paralyzed after injection with nanoprobe 2. They were then 
were beheaded and the heads were placed in fly saline.  The heads were then lysed using 
a probe sonicator and the lysate was centrifuged to pellet exoskeleton.  The supernatant 
was removed and 75 µL was used for chem ABPP with rhodamine azide.  Clicked lysate 
Figure 3.4: Western Blot on C57BL/6 Cerebellum Samples after NeutrAvidin pre-
clearing. Cerebellum samples were first incubated using NeutrAvidin beads. 
The supernatant was then separated on a 10% SDS-PAGE gel, transferred to 
nitrocellulose, and probed using StrepHRP (1:10000). There is still strong biotin 
staining in the 0 µM control lanes. 
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was run on a 12.5 % SDS-PAGE gel. Again, the gel did not show any fluorescence 
bands.  (Figure 3.6) 
 
 
 
3.3 Discussion 
  Nanoprobe 2 was designed to be a probe which could target calcium permeable 
AMPARs and provide information about which subunits we were targeting, thus 
identifying the subunit composition of this phenotype of receptors.  Nanoprobe 2 was 
designed from a philanthotoxin scaffold and an acrylamide electrophile was added for 
bioconjugation to the surface of the targeted protein and an alkyne handle for “click” 
conjugation to an azide functionalized reporter tag.   
  The synthesis of nanoprobe 2 that we designed was straightforward, however the 
key peptide coupling step of triBoc spermine to compound 7 ((S)-2-(6-
acrylamidohexanamido)-3-(4-(prop-2-yn-1-yloxy) phenyl) propanoic acid) proved to be 
more difficult than expected.  The synthesis of triBoc spermine involves the protection of 
Figure 3.5: In-gel fluorescence of Protophormia terraenovae samples 
labeled with nanoprobe 2. Protophormia terraenovae samples 
were labeled with DMSO, nanoprobe 2, and SMII103. BSA 
was run a control. No signal was seen in probe containing 
samples. 
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one of the primary amines with a trifluroacetatyl group, then the protection of the 
remaining primary amine with Boc, then the deprotection of the ethyl trifluroacetate 
group, and finally a column clean up step. (Scheme 3.2) The column clean-up is run with 
ammonia containing running solution and detection of the molecule is done by ninhydrin 
staining, as there are no easily detectable UV active moieties on the molecule.7  The 
highest yield reported for this sequence of synthetic steps is 50%, 7-8 thus there is a large 
amount of heterogeneity from batch to batch of triBoc spermine due to the difficult 
purification that is required. This heterogeneity could be leading to some of the issues 
that come in the peptide coupling experiment.  Also, the peptide coupling reaction 
between the carboxylic acid on compound 7 and the primary amine on triBoc spermine 
proceeds slowly and to only 55% completion.  Attempts were made to speed up the 
reaction by making an activated ester of the carboxylic acid, but these efforts were futile 
as it only seemed to impair the reaction even further.  Multiple peptide coupling 
conditions were attempted before choosing diisopropylcarbodiimide as our peptide 
coupling reagent.    
 
   
In imaging experiments with dissociated cultures of rat cerebellar neurons, 
nanoprobe 2 appears to be behaving similar to that of nanoprobe 1. Fluorescence 
Scheme 3.2: Synthesis of triBoc spermine 
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accumulation was observed in areas where synaptic regions are present in the bright field 
image. This indicates that nanoprobe 2 is binding to similar areas to that of nanoprobe 1.  
Nanoprobe 2 was designed to be a probe to be better targeted towards calcium permeable 
AMPARs, so it was encouraging that the fluorescence activity is similar to that of 
nanoprobe 1.  Also, it is encouraging that the modifications that were made to the 
philanthotoxin structure did not disrupt the binding of the probe. As stated in Section 
1.1.11, polyamine toxins target the open ion pore with the polyamine tail biding inside 
the ion channel and having the aromatic head act as a steric mass that prevents full 
passage though the ion conduction pore.  The main modifications to the philanthotoxin 
structure were made to regions on the aromatic head (see Scheme 3.1), so binding into 
the pore should not be disrupted.  Further study with AMPAR antagonists would 
conclusively determine if we are indeed targeting receptors that may be calcium 
permeable AMPARs. 
  We then assayed whole brain lysates for ionotropic glutamate receptor 
identification with chem ABPP in three variant species, dissociated cultures of embryonic 
rat neurons, sectioned brain samples of adult female mice, and neurons from 
Protophormia terraenovae.  All of these have known populations of receptors that are 
sensitive to polyamine toxins.  We applied nanoprobe 2 to these samples, lysed the 
protein, and then separated the lysate on SDS-PAGE gels.  With the dissociated culture of 
embryonic rat neurons, we did not find any bands on the gel using either in-gel 
fluorescence or Western blot analysis.  This analysis was performed on cultured cortex, 
midbrain, and cerebellar neurons. We hypothesized this may be due to the overall low 
expression of calcium permeable AMPARs.  Since the protein samples are from a 
primary source, there are myriad other proteins in the samples. Also, the amount of 
receptors is variable from culture to culture. So with a low amount of native protein 
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available, it is plausible that we could be labeling something but simply not able to detect 
the signal.  
  We then decided to use mature brain samples from C57BL/6 female mice.  
Samples of the cortex and the cerebellum were removed, treated with nanoprobe 2, and 
lysed with a probe sonicator.  The first set of gels was probed against streptavidin-HRP.  
Unfortunately, our first set of experiments resulted in positively labeled bands in the non-
labeled (0 µM probe) lanes in the areas where we would expect to see ionotropic 
glutamate receptors.  The cerebellum has a large amount of endogenous biotin present.6 
Biotin is present in many tissues as it is a required cofactor in oxidative metabolism for 
carboxylases; thus is heterogeneously distributed throughout tissues in the body.  In 
neurons, here is expression of biotinidase (a biotin recycling enzyme), and there is also 
the presence of active carrier-mediated biotin transport mechanisms. All of these add to 
the endogenous amount of biotin that is present in the brain.6 We tried adding 
NeutrAvidin beads into the lysate prior to the click reaction with azido biotin in an 
attempt to pre-clear any biotinylated proteins.  This was only marginally successful as 
subsequent gels still contained positive biotin bands in the control lanes, albeit less than 
that of the original. 
 
 
   
 
We decided to take a step back from the complex networks of the mammalian 
brain and see if nanoprobe 2 would work as an antagonist in insects as the glutamate 
receptor is reported in insects (Figure 3.6).  We obtained Protophormia terraenovae, a 
Figure 3.6: ClustalW alignment of GluA2 isoforms.  ClustalW alignment of the M2 
transmembrane domain of mouse, rat, human, and drosophila. The Q/R site is 
highlighted in blue and is conserved through species. 
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large fly species, for these experiments.  We first injected nanoprobe 2 into the abdomen 
of the flies and observed the behavior of the fly.  Flies showed lethargic effects including 
paralysis of wings, staggered walking, and slowed reaction to noise stimulus.  This was 
not present in flies injected with a DMSO control.  Flies were then beheaded to analyze 
their main neurons.  The lysates underwent click chemistry with FAM-5 azide and SDS-
PAGE gels were run.  Again, these results were inconclusive as the fluorescence gels 
showed no bands, however coomassie staining showed the presence of protein. This 
suggested to us that nanoprobe 2 is not covalently binding to the receptor of interest. 
  These results from all of the gel experiments taken together suggest that 
nanoprobe 2 is not covalently modifying the target protein (or other proteins). We made 
major changes to the structure of nanoprobe 1 in the design of nanoprobe 2, the largest 
being the removal of the photolabile core to a phenolic one.  This changed the position of 
the points of attachment for the ligands on nanoprobe 2 over nanoprobe 1.  Likely the 
most important difference between the two molecules is the distance between the 
polyamine ligand and the targeting electrophile.  In nanoprobe 2 this distance is much 
shorter, thus the electrophile is not exploring the same protein space as nanoprobe 1.  
Attachment to the receptor of interest involves the Michael addition of our acrylamide 
electrophile to a biological nucleophile on the surface of the receptor.  If there is not a 
suitable partner, then the covalent attachment will not occur.  The binding pocket of the 
AMPA receptor is quite greasy, composed of proline, isoleucine, and threonine,9 so it is 
quite possible that there are simply no competent nucleophiles present in the area of our 
electrophile.  Without this covalent attachment, the receptor is not tagged, thus any 
subsequent experiments into identification would lead to the non-result that we have 
observed. 
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3.4 Methods 
3.4.1 General Information 
  All reagents were purchased through Fisher Scientific (Fair Lawn, NJ, USA) 
unless otherwise noted. FAM-5 azide was purchased from Lumiprobe (Hallendale Beach, 
FL, USA).  All moisture sensitive reactions were done under an argon atmosphere using a 
syringe-septum cap technique. Dry dimethylformamide (DMF) and acetonitrile (MeCN) 
were purchased from Sigma Aldrich (St. Louis, MO, USA).  Analytical thin layer 
chromatography (TLC) was carried out on Merck Silica gel 60 F254 glass plates and 
visualized using UV light (254 nm), ninhydrin, or bromocrestol green staining. Sorbent 
Technologies (Atlanta, GA, USA) silica gel (230-450 mesh) was used for flash 
chromatography. 1H NMR and 13C NMR spectra were collected on a 400 MHz Bruker 
NMR spectrometer using the residual proton or carbon resonance of the solvent as the 
standard.  Chemical shifts are reported in parts per million (ppm).  The following 
abbreviations are used for peak multiplicities: s, singlet; d, doublet; dd, doublet of 
doublets; t, triplet; m, multiplet.  Mass spectra were measured using either a Waters ZQ 
for LCMS, or at the UMass Mass Spec facility for HRMS, UMass Amherst. 
3.4.2 Synthesis of Nanoprobe 2  
NH2
OH
O
CH3COCl, MeOH
reflux 15hrs NH2
O
O
HO HO
1  
Methyl Ester Protection of Tyrosine (1) 
   Acetyl chloride (15 mL, 210.9 mmol) was added slowly to methanol (110 mL) 
while stirring vigorously.  Tyrosine (5.59g, 30.6 mmol) was added and the solution was 
heated to reflux for 18 hours.  The solution was cooled to room temperature and the 
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solvent was removed in vacuo. (5.04 g, 94 % yield).  The product matched literature 
spectra and was used without further purification.10 
NH2
O
O
BOC2O
NaHCO3, EtOH
HO
HN
O
O
O
O
HO
1 2  
Boc Protection of Tyrosine Methyl Ester (2) 
  Compound 1 (5.04 g, 25.8 mmol) was dissolved in absolute ethanol (110 mL).  
Sodium bicarbonate (22.52 g, 268.1 mmol) and di-tert-butyl dicarbonate (8.42 g, 38.6 
mmol) were added and the reaction was stirred at room temperature for 24 hours.  The 
reaction was passed through a fritted funnel to remove sodium bicarbonate and the 
solvent was removed in vacuo.  The resulting white solid was spectroscopically identical 
to literature and was used without further purification. (6.53 g, 90%.) 10 
HO
HN
O
O
O
O
C3H3Br
K2CO3, DMF
2
O
HN
O
O
O
O3  
Methyl 2-( (tert-butoxycarbonyl) amino)-3-(4-(prop-2-yn-1-yloxy) 
phenyl)propanoate (3) 
 Compound 2 (5.00 g, 16.9 mmol) was dissolved in dry DMF (100 mL).  
Anhydrous potassium carbonate (7.05 g, 51.0 mmol) was added and the reaction mixture 
stirred for 30 min at 0°C. Propargyl bromide (80% solution in toluene, 3.02 g, 25.4 
mmol) of was added dropwise and the reaction mixture was allowed to warm to room 
temperature with stirring for 18 hours.  The reaction was then quenched with deionized 
water (100 mL) and extracted using ethyl acetate (3x 20 mL).  The solvent was removed 
in vacuo. The resulting yellow oil was spectroscopically identical to literature and was 
used without further purification. (4.43g, 67% yield) 11 
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O
HN
O
O
O
O
1 M anh. HCl
O
NH2
O
O
3 4  
 (S)-Methyl 2 amino-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoate(4) 
  Compound 3 (2.83 g) was deprotected using 1M anhydrous hydrochloric acid (50 
mL). The reaction mixture was stirred for 4 hours and hexanes (10 mL) was added to 
precipitate the HCl salt of the desired product. A solid white precipitate was filtered, 
dried, and was used without further purification as it was spectroscopically identical to 
literature. (1.28 g, 49%)11 
HO
O H
N
O  
6-Acrylamidohexanoic acid (5) 
   Hexanoic acid (5.17 g, 39.4 mmol) was combined with calcium hydroxide (5.34 
g, 44.5 mmol) in deionized water (70 mL).  A catalytic amount of hydroquione (1 mg, 9 
mmol) was added and the reaction stirred at 0°C for 20 min. Acryolyl chloride (3.6 ml, 
44.51 mmol) was added dropwise and the reaction mixture was stirred at 0°C for an 
additional 15 minutes on ice. Conc. hydrochloric acid (6 mL) was added drop wise until 
the product precipitated out.  The resulting pale brown solid was spectroscopically 
identical to literature and was used without further purification. (2.76 g, 67% yield) 12 
O
NH2
O
O
EDC, HOBt, DIPEA
4:1 ACN:DMF
HO
O H
N
O
O
NH
O
O
H
N
O
O
4 6
5
 
 (S)-Methyl 2-(6-acrylamidohexanamido)-3-(4-(prop-2-yn-1-
yloxy)phenyl)proanoate (6)  
Compound 5 (1.52 g, 8.24 mmol) was combined with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (1.39 g ,7.24mmol) and hydroxybenzyltriazole (1.11 
g ,7.18 mmol) in 4:1 acetonitrile:DMF (15 mL). This solution was stirred for 10 minutes, 
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then N,N-diisopropylethylamine (9.55 mL, 54.9 mmol) was added. The reaction mixture 
was stirred for an additional 30 minutes, and then compound 4 (1.28 g, 5.84 mmol) was 
added and stirred overnight at room temperature.  The reaction underwent an extraction 
with 3x10 mL of 1 M hydrochloric acid and 3x10 ml of 1M sodium chloride into 
dichloromethane and was dried over sodium sulfate to leave a white solid. (334 mg, 17%) 
1H NMR (400MHz , CDCl3) δ = 7.02 (d, J = 8.3 Hz, 2 H), 6.88 (d, J = 8.6 Hz, 2 H), 6.23 
(s, 1 H), 6.27 (s, 1 H), 6.16 - 6.05 (m, 2 H), 5.58 (d, J = 10.1 Hz, 1 H), 4.80 (q, J = 6.3 
Hz, 1 H), 4.64 (s, 2 H), 3.70 (s, 3 H), 3.37 - 3.22 (m, 2 H), 3.07 (dd, J = 5.6, 14.1 Hz, 1 
H), 2.99 (dd, J = 6.3, 13.9 Hz, 1 H), 2.56 - 2.50 (m, 1 H), 2.16 (t, J = 7.2 Hz, 2 H), 1.64 - 
1.44 (m, 5 H), 1.37 - 1.21 (m, 3 H), 1.21 - 1.04 (m, 1 H).  13C NMR (101MHz , CDCl3) δ 
= 172.2, 171.9, 165.3, 156.3, 130.7, 129.8, 128.5, 125.7, 114.6, 78.1, 76.7, 76.4, 75.2, 
55.4, 52.7, 51.9, 38.7, 36.5, 35.6, 28.5, 25.8, 24.4 LCMS (M/Z = 401.1), HRMS 
C22H28N2O5; calculated (M +Na)+= 423.1890; observed  (M + Na 423. 1892)+   
 
2-(6-acrylamidohexanamido)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid(7) 
Compound 6 (334.4 mg, 0.835 mmol) was dissolved in 1:1 THF: water (4 mL) 
and stirred at 0°C for 20 minutes. Lithium hydroxide (214.6 mg, 5.11 mmol) was added 
and the reaction mixture was stirred for 3 hours. The reaction was quenched with 3M 
hydrochloric acid until pH equal to 1 on pH paper. The resulting solution was extracted 
with ethyl acetate and dried over magnesium sulfate.  The solvent was evaporated in 
vacuo. (214 mg, 66 %). 1H NMR (400MHz ,Methanol-D4) δ = 7.20 - 7.14 (m, J = 8.6 Hz, 
2 H), 6.96 - 6.86 (m, J = 8.6 Hz, 2 H), 6.31 - 6.15 (m, 2 H), 5.65 (dd, J = 3.7, 8.2 Hz, 1 
H), 4.70 (d, J = 2.3 Hz, 2 H), 4.65 (dd, J = 4.9, 9.5 Hz, 1 H), 3.26 - 3.19 (m, 2 H), 3.16 
O
NH
O
O
H
N
O
O
6
LiOH
1:1 THF:H2O O
NH
OH
O
H
N
O
O
7
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(d, J = 4.8 Hz, 1 H), 2.96 - 2.85 (m, 2 H), 2.19 (t, J = 7.3 Hz, 2 H), 1.60 - 1.44 (m, 4 H), 
1.32 - 1.17 (m, 2 H) 13C NMR (101MHz ,Methanol-D4) δ = 174.5, 173.5, 166.7, 156.8, 
130.8, 129.8, 125.0, 114.6, 78.5, 75.3, 55.2, 53.8, 47.6, 38.8, 36.2, 35.2. LCMS 
(M+H=384.4); HRMS C21H26N2O5 calculated (M + Na)+=409.1734; observed (M+ Na)+ 
= 410.1781)  
H2N N N
H
N O
O
OO
O O
 
Tert-butyl (4-((3-aminopropyl)(tert-butoxycarbonyl)amino)butyl)(2-(((tert-
butoxycarbonyl)amino)ethyl)carbamate (8) 
Spermine (1.61g, 7.95 mmol) was dissolved in methanol (40 mL) and cooled to -
78°C using an acetone/dry ice bath for 20 minutes.  Ethyltrifluoroacetate (1.35 mL, 
1.12g) was added dropwise and reaction stirred at -78°C for 1 hour.  The reaction was 
then warmed to 0°C for one hour before addition of di-tert-butyl dicarbonate (6.85 g, 
31.3g).  The reaction mixture was warmed to room temperature and stirred overnight.  
Conc. ammonia was added dropwise until the pH equaled 11 on pH paper, and the 
reaction was stirred an additional 18 hours.  The solvent was then evaporated in vaccuo 
and a flash column was run using 70:10:1 CH2Cl2:CH3OH:ammonia to 50:10:1 
CH2Cl2:CH3OH:ammonia gradient as the mobile phase. The resulting pale yellow oil was 
spectroscopically identical to literature. (543 mg, 13.5 %) 7 
TriBoc spermine
DIC 4:1 ACN:DMF
O
NH
N
H
O
H
N
O
O
O
NH
OH
O
H
N
O
O
N
N
H
N
Boc
Boc
Boc
7
8
9
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 (S)-tert-butyl (3-(2-(6-acrylamidohexanamido)-3-(4-(prop-2-yn-
yloxy)phenyl)propanamido)propyl) (4-((tert-butoxycarbonyl)(3-((tert-
butoxycarbonyl)amino)propyl)amino)butyl)carbamate (9) 
Compound 7 (149.8 mg, 0.3876 mmol) was dissolved in 4:1 acetonitrile:DMF (2 
mL) and then added N,N-diisoproylcarbodiimide (127.2 mg, 157.9 uL, 1.00 mmol) and 
diisopropylethylamine (cat.). The reaction mixture was stirred for 20 minutes, and then 
compound 8 (676.2 mg, 1.34 mmol.) dissolved in DMF (2 mL) was added. The reaction 
mixture was stirred overnight and then extracted into ether (40 mL); the reaction mixture 
was washed with 1 N HCl (3x20 mL) and 1 N NaOH (3x 20 mL) and dried over 
magnesium sulfate.  The solvent was removed in vacuo. and the resulting residue was 
purified via preparative HPLC (minutes 1-5 75% water, 25% acetonitrile; minute 5-35 
5% water, 95% acetonitrile) (70 mg,  21%)) 1H NMR (400MHz ,CDCl3) d = 7.19 - 7.12 
(m, J = 8.6 Hz, 2 H), 6.96 - 6.87 (m, J = 8.3 Hz, 2 H), 6.30 (dd, J = 1.5, 16.9 Hz, 1 H), 
6.13 (dd, J = 10.4, 16.9 Hz, 1 H), 5.64 (dd, J = 1.4, 10.2 Hz, 1 H), 4.68 (d, J = 2.3 Hz, 2 
H), 3.33 (d, J = 6.1 Hz, 4 H), 3.33 (d, J = 19.7 Hz, 2 H), 3.23 - 3.01 (m, 9 H), 2.54 (t, J = 
2.3 Hz, 1 H), 2.22 (d, J = 6.8 Hz, 2 H), 1.73 (br. s., 2 H), 1.66 - 1.60 (m, 4 H), 1.54 (br. s., 
2 H), 1.48 (s, 13 H), 1.44 (s, 9 H), 1.36 - 1.27 (m, 2 H). LCMS (M+H) = 871.11 
O
NH
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N
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HN
O
N
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H
N NH2
 
 (S)-6-acrylamido-N-(1-((3-((4-((3-aminopropyl) 
amino)butyl)amino)propyl)amino)-1-oxo-3-(4-(prop-2-yn-1-yloxy)phenyl-2-
yl)hexanamide (10) 
   Compound 9 (70 mg, 0.12 mmol) was deprotected using 3M anhydrous 
hydrochloric acid (2 mL) in ethanol. The reaction stirred for 18 hours and was 
precipitated as the HCl salt using hexanes (1 mL). (9.8 mg, 14%)  LCMS (M+H=571.6) 
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 (S)-Tert-butyl (3-(2-(6-acrylamidohexanamido)-3-(4-((4-(2-(3',6'-dihydroxy-3-oxo-
3H-spiro[isobenzofuran-1,9'-xanthen]-6-ylcarboxamido)ethyl)-1H-1,2,3-
triazol-1-yl)methoxy)phenyl)propanamido)propyl)(4-((tert-
butoxycarbonyl)(3-((tert-
butoxycarbonyl)amino)propyl)amino)butyl)carbamate(11) 
Compound 9(27 mg, 0.031 mmol) was combined with 10uL of 10 mM stock 
FAM-5 azide in DMSO, 5% copper sulfate pentahydrate (0.032 mmol) dissolved in 
water, and 10% sodium ascorbate (0.0313 mmol) dissolved in water  and was stirred for 
48 hours.  The resulting solution was extracted into CH2Cl2 and the solvent was removed 
in vacuo. (9.7 mg, 1%)  LCMS= 1329.19. 
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(S)-N-(2-(1-((4-(2-(6-acrylamidohexanamido)-3-((3-((4-((3-
aminopropyl)amino)butyl)amino)propyl)amino)-3-
oxopropyl)phenoxy)methyl)-1H-1,2,3-triazol-4-yl)ethyl)-3',6'-dihydroxy-3-
oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6-carboxamide (12): 
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Compound 11 (9.7 mg, 0.001 mmol) was deprotected using 3M anhydrous 
hydrochloric acid (2 mL) in ethanol. The reaction stirred for 18 hours and was 
precipitated as the HCl salt using hexanes (1 mL). (3.1 mg, 5%) LCMS= 1028.19 
3.4.3 Dissociated Cerebellar Cell Culture 
Primary dissociated cerebellar cell cultures were prepared from embryonic day 
E18-19 Sprague-Dawley rat embryos and were cultured on polylysine-coated coverglass 
(12mm, 1.0 size) in serum-containing media identical to previous reports.13 Cells were 
grown in 5% CO2 at 37°C. All animal care and experimental protocols were approved by 
the Animal Care and Use Committee at the University of Massachusetts Amherst, 
Amherst, MA, USA. 
3.4.4 Dissociated Cortex, Midbrain, and Cerebellar Cell Culture 
Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared 
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2 
T-Flasks coated in poly-lysine in serum containing media identical to previous reports.14 
Cerebellar culture media was supplemented with 1M potassium chloride (1 mL in 50 mL 
of total media)13 Cells were grown in 5% CO2 and at 37°C. All animal care and 
experimental protocols were approved by the Animal Care and Use Committee at 
University of Massachusetts, Amherst, Amherst, MA, USA. 
3.4.5 Live Cell Imaging with Nanoprobe 2 
Cells were imaged using a 488 nm laser line on a Yokogawa Spinning Disc 
Confocal (Tokyo, Japan) on a Nikon Eclipse Ti series microscope (Nikon Corps Tokyo, 
Japan) with a CFI Plan Apo VC 100x 1.4 NA oil objective lens (Nikon) was used for 
imaging experiments. Images were acquired using an Andor cooled EMCCD camera 
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(Andor Technology Belfast, UK) and MetaMorph software (Molecular Devices 
Sunnyvale, CA USA). 
Cells were removed from their home media and washed three times in 
extracellular buffer solution (138 mM NaCl, 1.5 mM KCl, 1.2 mM MgCl2, 5 mM 
HEPES, 2.5 mM CaCl2, and 14 mM glucose at pH 7.4). They were then placed into a 
static bath of extracellular solution and imaged for a minute to collect the background 
fluorescence.  2 µM nanoprobe 2 was added to the bath for 5 minutes at room 
temperature and cells were washed three more times with extracellular solution.  Cells 
were then imaged for 5 minutes to collect fluorescent data.  
3.4.6 Image Analysis of Confocal Imaging Data 
  Images were analyzed using ImageJ (U.S. National Institutes of Health, 
Bethesda, MD, USA).  Fluorescence was quantified using ROI (region of interest) 
analysis of multiple regions placed over putative synaptic sites and areas of background. 
The mean fluorescence intensity was background subtracted and fluorescence intensities 
were plotted using GraphPad Prism (La Jolla, CA, USA).  Two image series were 
analyzed and the data combined for a total of 118 ROIs analyzed.   
3.4.7 Chemical Activity Based Protein Profiling on Dissociated Cultures of Rat Cortex, 
Midbrain, and Cortex Neurons 
   25 cm2 T-flasks of cortex, mid-brain, and cerebellar neurons were grown to they 
were synaptically active (DIV 14-18).  Flasks were washed three times with extracellular 
recording buffer. 0, 1, 3, or 10 µM of nanoprobe 2 dissolved in 7 mL of extracellular 
solution with 20 µM glutamate was applied for 5 minutes at room temperature. Control 
solutions containing equimolar concentrations of nanoprobe 2 and NAS were also made 
for additional flasks. Flasks were then washed three more times with extracellular 
solution.  1 ml of lysis solution (1 x PIC, 1x PBS) was added to each flask and cells were 
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scrapped to remove from sides of the T-flask. Cells were lysed with a probe sonicator 
30% power for 1 minute, and the membrane portions were spun down.  The membrane 
pellet was lysed again using the same conditions and a BCA assay was run to quantitate 
protein concentrations.  Master mixes for click solutions were prepared with 1 mM 
CuSO4*5H2O (50 mM stock), 100 µM THPTA (1.7 mM stock), and freshly prepared 1 
mM TCEP (50 mM stock).  These incubated for 10 minutes and 10 µM of either 
rhodamine azide or biotin azide were then added. A separate control master mix was 
prepared by substituting deionized water in for the CuSO4*5H2O. 50 µL of cell lysate 
were removed and the appropriate master mix was added to the tube with the reaction 
going for one hour. Samples were then separated on a 10% SDS-PAGE gel.  For in-gel 
fluorescence experiments, gels were placed into 10% acetic acid for a minimum of 10 
mintures and imaged using a Typhoon imager.  For Western blot experiments, proteins 
were transferred to a nitrocellulose membrane and probed against streptavidin HRP 
(1:10,000) (Thermo Scientific, Waltham, MA, USA). HRP was activated using Super 
Substrate West Pico Chemiluminescent substrate (Thermo Scientific). 
Chemiluminescence was measured using a PxSys imaging system.  
3.4.8 Chemical Activity Based Protein Profiling of Cortex and Cerebellum Samples from 
C57BL/6 Female Mice 
Brain samples were kindly provided by Jesse Mager’s lab in Veterinary and 
Animal Sciences at UMass, Amherst.  Brain samples were removed after cervical 
dislocation of the mice and placed into extracellular solution containing 20 µM glutamate 
and 0, 1, or 3 µM nanoprobe 2 or solutions containing 20 µM glutamate with equimolar 
mixtures of nanoprobe 2 and NAS at the same concentration as above.  Brain samples 
were allowed to incubate in these solutions for 15 minutes and were then washed three 
times with extracellular solution.  Samples were then lysed using a probe sonicator and 
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underwent chem ABPP with biotin azide similar to Section 3.4.7.  Lysates were separated 
on a 10% SDS-PAGE gel and then probed using streptavidin-HRP.   
  100µL of cell lysate to pre-clear with streptavidin beads (NeutrAvidin agrose 
resin, Thermo Scientific) and run the supernate through the chem ABPP process.  The 
supernate was loaded onto a 10 % SDS-PAGE gel, separated, and transferred to a 
nitrocellulose membrane.  Western blots were done against streptavidin-HRP.  HRP was 
detected using SuperSignal West Pico Chemiluminescent subtrate, and imaged using the 
PxSys imaging system.  
3.4.9 Chemical Activity Based Protein Profiling on Neurons from Protophormia terraenovae 
Protophormia terraenovae were a gift from Dr. John G. Stoffolano Jr., UMass, 
Amherst Plant, Soil, and Insect Science. P. terraenovae were obtained at their young 
adult stage and kept in a cage with sugar water.  Flies were removed from their 
confinement with a 50 mL Falcon tube, anesthetized with chloroform, and injected with 
10 µL of 30µM nanoprobe 2 or DMSO with a 27.5 G needle into the thorax.  Flies were 
beheaded and the heads were placed in fly saline (140 mM NaCl, 5.0 mM KCl, 7.0 mM 
CaCl2*2H2O, 1.0 mM MgCl2*6H2O, 5.0 mM TES, 4.0 mM NaHCO3, 5.5 mM trehalose, 
and 9.4 mM sucrose, pH= 6.9).  The heads were then lysed using a probe sonicator and 
the lysate was centrifuged to pellet exoskeleton.  The supernatant was removed and 75 
µL was used for chem ABPP with FAM-5 azide.  Tagged lysate was separated on a 12.5 
% SDS-PAGE gel. In-gel fluorescence was measured using a Typhoon 9210 imager. 
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CHAPTER 3  
PHOTOCHEMCIAL PHLIANTHOTOXIN BASED PROBE FOR THE DETECTION OF 
CALCIUM PERMEABLE AMPA RECEPTORS 
4.1 Introduction 
  From experiments with nanoprobe 2 (see Chapter 3 for full details), it became 
clear that our electrophile was not attaching to the surface of the receptor, even though 
imaging studies suggested that we were targeting that same receptors as nanoprobe 1.  
We had assumed the acrylamide moiety on nanoprobe 2 would conjugate to the receptor 
of interest through proximity accelerated reactivity.  In the absence of a suitable 
nucleophile for bioconjugation, the nanoprobe 2 will simply be removed during the 
multiple wash steps that occur during each activity based protein profiling experiment 
that was performed to determine the receptor subtype we were targeting.  Philanthotoxin, 
and other polyamine toxins, are use-dependent meaning that only the open channels are 
blocked. Use-dependency in polyamines has been well characterized 1 and there is a 
voltage dependency which is also associated with them.  Typically, intracellular 
polyamines block AMPARs internally and result in an inward rectification of the evoked 
current. Our polyamines are applied externally and prevent current influx.  To remove 
our polyamines, we must depolarize the membrane, which releases the block.1 Since our 
acrylamide electrophile was not tagging, we can hypothesize that either it was being 
excised from the channel before the Michael addition could occur, or there was not a 
competent nucleophilic partner for crosslinking. 
  Keeping the current probe design in mind, we decided that we needed to change 
our electrophile to one that would be less discriminating for covalent attachment to our 
protein of interest.  We decided to use an aryl azide, which adds to a protein of interest 
via UV-induced photolysis, thus making nanoprobe 3 a photoaffinity probe.  Once 
photolysed, the probe has a highly reactive intermediate which can react with the closest 
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neighboring partner, thus labeling the protein with the probe.2 A good photoaffinity probe 
must be inert when added, only reacting when photolysed with UV-light; thus UV-
activation of the photophore must not destroy the biomolecule of interest, and lifetime of 
the activated photophore must be short, shorter than that of the ligand receptor 
interaction.3 Once the activated photophore binds, the binding is covalent, and in an ideal 
probe should not disrupt the natural dynamics of the receptors that it labels. The use of 
photoaffinity labels also allows for identification of the amino acids that are involved in 
binding to the probe, thus making an affinity label a good system for the detection of 
calcium permeable AMPARs.  
Previous photolabile philanthotoxin based probes have been synthesized. 4 
Nakanishi and co-workers developed a photolabile probe targeted towards nicotinic 
acetylcholine receptors (nAChRs), which are also targets of polyamine toxins. Much like 
AMPARs, nAChRs are also ligand-gated, ion channels, but are sensitive to acetylcholine 
and nicotine.  They are comprised of five transmembrane subunits and are located in the 
synaptic cleft. In their probe, the scaffold was based off of philanthotoxin 434 rather than 
the philanthotoxin 433 that nanoprobe 2 and 3 are based on. The numbering system that 
is used for these polyamines is to count the methylene units contained in the polyamine 
tail.1a, 4bThis, and the addition of 125I, makes their photolabile probe have higher affinity 
for nAChRs over AMPARs.  Also, the 125I addition allowed for radiolabeling 
experiments to study labeled receptors. 4b Our probe lacks the radiolabel, but has an 
orthogonal handle which allows for affinity purification of the labeled lysate. 
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4.2 Results 
4.2.1 Nanoprobe 3 Design 
  We kept the major features of nanoprobe 2 in mind when designing nanoprobe 3.  
Much like before, we designed nanoprobe 3 from a philanthotoxin scaffold.  This was 
done to create a probe that kept the features of philanthotoxin, yet could provide 
information about the receptors we are targeting. For nanoprobe 3, we changed the 
phenolic hydroxide to an azide for photoreactivity and bioconjugation to the surface of 
the receptor. We then changed the butyl chain so it contains a Poc group for attachment 
of an azide functionalized reporter tag. (Scheme 4.1) 
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4.2.2 Initial Photolysis Testing With Nanoprobe 3 
  To confirm that nanoprobe 3 would undergo photolysis in times that would be 
biologically relevant the molecule was irradiated under UV light (365 nm) for 1-10 
Scheme 4.1: Synthesis of nanoprobe 3 
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minutes to determine the minimum amount of time it takes for generation of the UV 
byproduct. Formation of the nitrene product was monitored via LCMS analysis.  We 
determined that four minutes of irradiation by UV light is sufficient for biological studies. 
(Figure 4.1) This is important because we did not want our protein to be degraded due to 
the UV-light. 
 
   
Next, we wanted to confirm that nanoprobe 3 could label proteins.  We 
performed in vitro studies using nanoprobe 3 to test the photolysis reaction using bovine 
serum albumin (BSA) and lysozyme.  BSA and lysozyme were irradiated for 4 minutes 
using UV light with nanoprobe 3 and then the proteins were subjected to chem ABPP as 
described in Section 3.2.3 with rhodamine azide.  Proteins were then separated on a 10% 
SDS-PAGE gel and fluorescence was visualized using a Typhoon 9210 gel scanner. 
(Figure 4.2) The results demonstrated that nanoprobe 3 is able to covalently label proteins 
in vitro.  
 
5.758 Peak 1 - ZQ F1 Scan 100.00-1000.00 ES+, Continuum, CV=60
105.9 235.2
276.3
383.4 588.7
In
te
ns
ity
0.0
5.0x105
1.0x106
1.5x106
2.0x106
m/z
100.00 200.00 300.00 400.00 500.00 600.00 700.00 800.00 900.00 1000.00
Figure 4.1: Mass spectrum of nanoprobe 3 precursor after 4 minute UV 
irradiation.  Compound 17 (mw=276) was irradiated for 4 minutes with 
365 nm light. Formation of the nitrene (mw=235) was observed. 
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4.2.3 Chemical Activity Based Protein Profiling of Cortex, Midbrain, and Cerebellum 
Neurons with Nanoprobe 3 
  With the information that nanoprobe 3 was able to label proteins using in vitro 
conditions, we next moved into labeling neurons to determine which receptors we were 
targeting. Nanoprobe 3 is designed to targets calcium permeable AMPA receptors much 
like nanoprobe 1 and 2, so by performing chem ABPP we should be able to determine 
which receptor subtypes we are targeting. To 25 cm2 T-Flasks, 10 µM of nanoprobe 3 
was applied for 5 minutes at room temperature and then the flasks were irradiated for 4 
minutes with UV-light. Equimolar NAS to nanoprobe 3 controls were also done at the 
same time. Cells were lysed using a probe sonicator, and the membranes were pelleted.  
The membrane pellet was then lysed and the lysate underwent chem ABPP with either 
azido rhodamine or azido biotin.  Labeled lysates were separated on a 10% SDS-PAGE 
gel. For rhodamine labeled protein gels, fluorescence was measured using a Typhoon 
9210 scanner.  For biotin labeled protein, 10 % SDS-PAGE gels were used to separate 
protein, transferred to a nitrocellulose membrane, biotin was probed for using 
Figure 4.2: In-gel fluorescence of BSA and lysozyme labeled with nanoprobe 3. 
BSA (70 kDa) and lysozyme (20 kDa) were labeled and irradiated with 
nanoprobe 3 and separated using 10% SDS-PAGE gels. Labeling with 
nanoprobe 3 was seen in when both light and copper were present. 
BSA Lysozyme 
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streptavidin-HRP, and imaged on a BioRad Protein Box. (Figure 4.3) Gels did not show 
any labeled fluorescent bands. This may be due to the electrophile not being able to bind 
to our protein of interest. 
 
 
 
4.2.4 Fixed Cell Imaging of Hippocampal and Cerebellar Neurons with Nanoprobe 3 
  Since the gel experiments appeared to lack any covalent labeling of the natively 
expressed AMPARs, we took a step back and went back to imaging experiments with 
neurons.  Nanoprobe 3 contains an alkyne group for conjugation to the reporter tag, so it 
is necessary to fix the neurons before the copper catalyzed click reaction of the reporter 
tag.  This is due to the toxic effects of copper on proteins. Neurons were labeled with 
nanoprobe 3 for 5 minutes at room temperature and then irradiated with UV-light for 4 
Figure 4.3: Cerebellum samples probed with nanoprobe 3. (Left) 
Cerebellum samples run on a Western blot, probed with Strep-
HRP (1:10000) (Right) In-gel fluorescence of cerebellum 
samples with rhodamine azide. No signal was seen in probe 
labeled neuronal protein lanes. 
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minutes. Equimolar NAS to nanoprobe 3 controls were also prepared. Neurons were then 
fixed in 4% paraformaldehyde for 10 minutes. They immediately underwent chem ABPP 
with rhodamine azide and were washed ten times with 1x PBS. Coverslips containing 
cells were then mounted on a glass slide with ProLong Gold Antifade. Coverslips were 
imaged using epifluorescence microscopy; however fluorescent images were taken of all 
samples. (Figure 4.4) Fluorescence accumulation was seen in samples targeted by 
nanoprobe 3 and that had also been irradiated with UV-light. However, fluorescence 
accumulation was also seen in the dark samples, and the equimolar NAS and nanoprobe 3 
samples. We also saw fluorescence accumulation in samples which contained only 
rhodamine azide. This suggests that the fixation process may have permeabilized the 
membrane allowing for rhodamine azide to cross. 
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4.2.5 Fixed Cell Imaging of CHO Cells with Nanoprobe 3 
  Since we received confusing results from our imaging experiments with 
nanoprobe 3, we decided to move into a simpler heterologous system of CHO cells 
transfected with GluA1 (L497Y)-pIRES2-eGFP. Nanoprobe 3 was applied to the cells for 
5 minutes and then irradiated for 4 minutes with UV light.  Equimolar NAS to nanoprobe 
3 controls were also prepared. Cells were then fixed using 4% paraformaldehyde and then 
conjugated with rhodamine azide. Coverslips containing cells were then mounted onto 
Figure 4.4: Fixed neuronal imaging with nanoprobe 3. DIV 18hippocampal neurons 
were labeled with nanoprobe 3, irradiated, and fixed in 4% paraformaldehyde. 
They were then labeled with rhodamine azide with and without copper for click 
chemistry.  Controls were done in the presence of NAS, with just rhodamine, 
and with nothing at all.  Fluorescence signal was averaged over the positive 
controls (n=8) and was set for all of the images.  Fluorescence accumulation is 
seen in all cases where rhodamine azide is present. 
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coverglass with ProLong Gold Antifade. Coverslips were imaged using epifluorescence 
microscopy.  Again, fluorescence was seen in all cases, both probed containing samples 
and the controls.  (Figure 4.5) 
 
   
 
 
We thought that the increase in fluorescence in all samples may be due to the 
probe not being fully washed away.  Multiple washes were performed ranging from 3-24 
washes with 1x ECS prior to being fixed with 4% paraformaldehyde.  Cells were then 
orthogonally targeted with rhodamine azide and imaged via epifluorescence microscopy.  
Again, fluorescence was seen in all cases.  (Figure 4.6) 
Figure 4.5: GluA1 CHO cells labeled with nanoprobe 3. GluA1 CHO cells were 
labeled with nanoprobe 3, irradiated, and fixed with 4% paraformaldehyde. 
Fluorescence accumulation was averaged for with and without copper.  The 
samples containing no copper had a higher fluorescence accumulation. 
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We then hypothesized that the polyamine portion of nanoprobe 3 might not able 
to leave the ion channel.  To facilitate this, we depolarized the membrane using a high 
KCl solution (1M).  We placed this solution on the cells 1-4 times, washing three times in 
between with 1x ECS.  Cells were then fixed with 4% paraformaldehyde and labeled with 
rhodamine azide.  Cells were then imaged using epifluorescence microscopy.  Again, 
there were large amounts of fluorescence in all cases. (Figure 4.7) 
 
Figure 4.6: Nanoprobe 3 labeled GluA1 CHO cells after multiple ECS washes. GluA1 
CHO cells were labeled with nanoprobe 3, irradiated, washed 24 x 1mL with 1x 
ECS, and then fixed with 4% paraformaldehyde. Fluorescence was set for the 
with UV light samples.  Fluorescence accumulation is similar in both cases. 
Figure 4.7: Nanoprobe 3 labeled GluA1 CHO cells after KCl washes. GluA1 CHO 
cells were labeled with nanoprobe 3, irradiated, washed 4 x 1mL with 1M 
KCl, and then fixed with 4% paraformaldehyde. Fluorescence was set for the 
with UV light samples.  Fluorescence accumulation is similar in both cases. 
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4.2.6 Chemical Activity Based Protein Profiling with GluA1 CHO Cells 
  To confirm that it is just the polyamine that is binding into the channel and that 
our aryl azide electrophile is not tagging, chem ABPP was run on GluA1 CHO cells.  To 
60 mm2 petri dishes, solutions containing 10 µM nanoprobe 3 were placed on for 5 
minutes at room temperature.  Dishes were then irradiated for 10 minutes under UV-light 
(no irradiation was used as a control) and cells were lysed using a probe sonicator.  The 
membranes were then pelleted and the membrane pellet was then lysed.  The lysate was 
then conjugated with biotin azide and separated on 10% SDS-PAGE gels.  Biotin was 
probed for by streptavidin-HRP and imaged using a BioRad imaging system.  (Figure 
4.8) 
 
Figure 4.8: Western blot of GluA1 CHO cells labeled with nanoprobe 3. GluA1 CHO 
cells were labeled with nanoprobe 3 and irradiated. Controls were performed 
with CHO cells labeled with malemide alkyne and BSA. All samples were 
lysed, separated on 10% SDS-PAGE gels, transferred to a nitrocellulose 
membrane, and probed using streptavidin-HRP. Signal was only seen in the 
positive controls, not in samples labeled with nanoprobe 3. 
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4.3 Discussion 
  Nanoprobe 3 was designed from a scaffold of philanthotoxin-433.  Much like 
nanoprobe 2, the rationale for designing this probe was to allow us to determine which 
subunits comprise calcium permeable AMPARs. To do so, we designed the probe so that 
it contained an aryl azide for photocrosslinking bioconjugation to the surface of the 
receptor. Mass spec experiments were conducted to determine the minimum amount of 
time that is need to fully photolyse the probe, which was determined to be four minutes. 
Initial testing of the probe was conducted in vitro using BSA and lysozyme and 
demonstrated that we were able to label both proteins.  
We then began testing nanoprobe 3 in neurons. Initial testing took place in 
dissociated cultures of rat cortex, midbrain, and cerebellar neurons. We probed using 
azido labeled rhodamine, fluorescein, and biotin for the detection of labeled subunits. The 
in-gel fluorescence and Western blot data showed that nanoprobe 3 is not covalently 
binding to the receptors of interest, or for that matter, any receptors in the neuronal 
samples. However, coomassie staining showed that there was indeed protein present on 
the gels and our control samples of BSA that were irradiated with the same probe work. 
A subsequent silver stain was done on other gels to again show the presence of protein, 
and to determine if there is any difference in labeling. (Figure 4.9) We were not able to 
visualize any fluorescent bands using either the fluorophore azide or the biotin azide, 
suggesting that the probe was not covalently attaching to the surface of the protein. 
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We then wanted to see if we are targeting the same receptor sites that nanoprobe 
1 and nanoprobe 2 targeted. In this case, we were not able to do live cell imaging as we 
did before, as we need to use copper to attach our reporter tag to the probe. Copper can be 
very toxic when introduced to biological systems at the amounts needed to catalyze click 
reactions.  Unlike nanoprobe 2, the addition of the reporter prior to cell imaging would be 
difficult as nanoprobe 3 contains both an azide, albeit an arylazide, and alkyne on the 
same molecule. We wanted to limit these toxic effects, so we fixed the neurons prior to 
applying azido-rhodamine for visualization. Here, we received very confusing results as 
some coverslips behaved as we expected and others did not. Our control coverslips, those 
that were non-irradiated and/or contained NAS, had fluorescence accumulation equal to 
or higher than that of the fully irradiated probe samples. This could be due to nanoprobe 
3 being internalized in vesicles prior to fixation with 4% paraformaldehyde. 5 Here, we 
could not be able to tell if nanoprobe 3 was attached to the surface of the receptor, on that 
Figure 4.9: Silver stain of SDS-PAGE gel of nanoprobe 3 labeled cerebellum 
samples.  Protein is present when the gel is silver stained, however, we 
do not see any protein bands in the fluorescence gels or the Western 
Blots. 
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it was present when the cells were fixed. Also, the rhodamine dye might be an issue as 
well. (Figure 4.4) In control samples in which only rhodamine azide was present, there 
was a large amount of somal staining, as well as dendritic staining. This suggests that the 
rhodamine azide is non-specifically targeting the membranes even after fifteen wash 
steps with 1x PBS. We cannot use a green fluorophore, as neurons autofluorescence at 
the 488 nm excitation for FITC and, as a result, use of another red fluorophore would 
give us better information.  
We then moved into a heterologous system of CHO cells stably transfected with 
GluA1. This represents a model calcium permeable AMPA receptor. GluA1 CHO cells 
were subjected to the same treatment as the neurons and probed using azido rhodamine. 
As with the neurons, we observed prodigious staining of the cell body which appeared to 
be non-specific. We wanted to then test if we could possibly remove nanoprobe 3 from 
the ion channel through either multiple wash steps or through depolarization of the 
membrane. Polyamine toxins block the ion current that goes through glutamatergic 
receptors and in neurons would be removed when the electrochemical gradient in the 
membrane shifts and depolarizes the membrane.6 This can also be done through chemical 
methods by using a high KCl solution. GluA1 CHO cells were washed up to 24 times 
with 1x PBS to try to remove the probe from the ion channel. GluA1 CHO cells were also 
washed with 1M KCl up to four times to depolarize the membrane, again to try to remove 
nanoprobe 3 from the ion channel before fixation. Again, there was no significant 
difference in cells that were either washed or depolarized compared to the control.  
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We then tried chem ABPP on GluA1 CHO cells this time affixing biotin azide to 
the probe. Controls were done using non-transfected cells labeled with malemide alkyne 
(Figure 4.10). Cells were irradiated for 10 minutes in this case to ensure that nanoprobe 3 
was labeling. Probing with streptavidin-HRP showed that nothing was labeled in the 
probe lanes, but the control lanes were labeled. This means that our click conditions are 
working just fine, but nanoprobe 3 is not. One potential reason is that the nitrene that is 
formed is reacting with water in the binding pocket.7 When the activate photophore is 
formed, it is indiscriminate in its binding partner and will react with to the closest 
neighboring molecule. In this case, it could be the OH of water and not the CH of the 
nearest amino acid in the binding pocket. All of these results, taken together, suggest that 
nanoprobe 3 does not function as a suitable probe for the detection of calcium permeable 
AMPARs.  
A better probe should take into account some of the design details that were 
incorporated into nanoprobe 1. The main difference between nanoprobe 1 and 
nanoprobes 2 and 3 is the placement of the electrophile to the targeting polyamine. It 
might be fruitful to move the position of the electrophile so that it can explore the same 
target space as nanoprobe 1. A better design for these nanoprobes will be described in 
chapter 6. 
Figure 4.10: CHO cells labeled with malemide alkyne with and without 
copper 
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4.4 Methods 
4.4.1 General Methods 
  All reagents were purchased through Fisher Scientific (Fair Lawn, NJ, USA) 
unless otherwise noted. FAM-5 azide was purchased from Lumiprobe (Hallendale Beach, 
FL, USA).   All moisture sensitive reactions were done under an argon atmosphere using 
a syringe-septum cap technique.  Dry dimethylformamide (DMF) and acetonitrile 
(MeCN) were purchased from Sigma Aldrich (St. Louis, MO, USA).  Analytical thin 
layer chromatography (TLC) was carried out on Merck Silica gel 60 F254 glass plates 
and visualized using UV light (254 nm), ninhydrin or bromocrestol green stain. Sorbent 
Technologies (Atlanta, GA, USA) silica gel (230-450 mesh) was used for flash 
chromatography. 1H NMR and 13C NMR spectra were collected on a 400 MHz Bruker 
NMR spectrometer using the residual proton or carbon resonance of the solvent as the 
standard.  Chemical shifts are reported in parts per million (ppm).  The following 
abbreviations are used for peak multiplicities: s, singlet; d, doublet; dd, doublet of 
doublets; t, triplet; m, multiplet.  Mass spectra were measured using either a Waters ZQ 
for LCMS, or at the UMass Mass Spec facility for HRMS, UMass Amherst. 
4.4.2 Synthesis of nanoprobe 3 
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13  
 (S)-2-amino-3-(4-nitrophenyl)propanoic acid(13) 
  L-phenylalanine (15.0 g, 90.8 mmol) was dissolved in H2SO4 (45 mL) and a 
mixture of HNO3 (4.50 mL, 108.9 mmol) in H2SO4 was added dropwise at 0°C. The 
solution was warmed to room temperature and stirred for 4 hours and then poured onto 
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ice (50 g) and neutralized with solid NaOH until pH equaled 7 using pH paper. A solid 
white precipitate was filtered, dried, and was used without further purification as it was 
spectroscopically identical to literature (10.41 g, 55 % yield).8 
OH
O
NH2O2N
O
O
NH2O2N
SOCl2
Reflux, EtOH
13
14
 
 (S)-Ethyl 2-amino-3-(4-nitrophenyl)propanoate (14) 
  To a stirred suspension of compound 13 (5.0 g, 23 mmol) in ethanol (40 mL), 
SOCl2 (2.07 mL, 28.5 mmol) was added dropwise and the reaction was heated to reflux 
overnight. The solvent was removed in vacuo and the product was purified via column 
chromatography using 10:1 CH2Cl2:CH3OH as the mobile phase. A solid white 
precipitate was filtered, dried, and was used without further purification as it was 
spectroscopically identical to literature (2.97 g, 53% yield) 9 
O
O
NH2O2N
O
O
NH2H2N
SnCl2
Reflux, EtOH14 15  
(S)-Ethyl 2-amino-3-(4-nitrophenyl)propanoate(15) 
  Compound 14 (2.95 g, 338.8 mmol) was dissolved in ethanol (50 mL) and was 
treated with Sn (II)Cl2 (5.92 g, 26.3 mmol) at reflux for 18 h. The solution was then 
cooled to room temperature, poured on ice (50 g), and made basic (pH equaled to 9) 
using sat. NaHCO3. The solution was then filtered through Celite and washed with 
CH2Cl2.  It was then extracted with brine, dried over MgSO4 (anhyd.), and the solvent 
was removed in vacuo.  The product was recovered as a white solid. (2.97 g, 53% yield)  -
1H NMR (400 MHz, CDCl3) d ppm 6.98 (d, J=8.34 Hz, 2 H) 6.63 (d, J=8.34 Hz, 2 H) 
4.17 (q,J=7.16 Hz, 11 H) 3.65 (dd, J=7.45, 5.43 Hz, 5 H) 2.98 (dd, J=13.64, 5.31 Hz, 6 
H) 2.77 (dd, J=13.77, 7.71 Hz, 7 H) 1.26 (t, J=7.20 Hz, 17 H).  
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 (S)-Ethyl 2-amino-3-(4-azidophenyl)propanoate (16) 
  Compound 15 (1.40 g, 4.5 mmol) was dissolved in aqueous 2 N HCl and cooled 
to 0°C. To that, NaNO2 (319 mg, 4.6 mmol) dissolved in water (3.6 mL) was slowly 
added. The reaction was stirred for 15 minutes and NaN3 (301 mg, 4.6 mmol) dissolved in 
water (7.2 mL) was added dropwise.  The reaction mixture was then warmed to room 
temperature and then stirred for an additional 30 minutes. The reaction mixture was then 
poured into deionized water (50 mL) and made basic with saturated NaHCO3. The 
solution was extracted into ethyl acetate (3 x 20 mL), dried over anhydrous sodium 
sulfate, and filtered. The solvent was removed in vacuo. The product was recovered as a 
white solid. (1.40g, 89% yield) 1H NMR (400 MHz, CDCl3) ppm 7.18 (d, J=8.34 Hz, 2 
H) 6.91 - 6.97 (m, 2 H) 4.15 (q, J=7.07 Hz, 13 H) 3.03 (dd, J=13.64, 5.31 Hz, 6 H) 2.84 
(dd, J=13.64, 7.58 Hz, 6 H) 1.20 - 1.27 (m, 21 H). 
O
O
NH2N3
O
O
HN
N3
O
O
TEA
Propargyl chloroformate
DCM
16 17
 
 (S)-Ethyl 3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy) carbonyl) amino)propanoate 
(17) 
  Compound 16 (1.32 g, 5.63 mmol) and triethylamine (942 µL, 6.76 mmol) were 
dissolved in CH2Cl2 (5 mL) and cooled to 0°C. Propargyl chloroformate (550 µL, 5.63 
mmol) was dissolved in CH2Cl2 (30 mL) and was added slowly to the reaction mixture.  
The reaction was warmed to room temperature and stirred overnight. The reaction 
mixture was diluted with CH2Cl2 and underwent a water work-up (3 x 20 mL). The 
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extract was dried over anhydrous sodium sulfate, filtered, and then evaporated in vacuo. 
The residue was purified using column chromatography using 10:1 CH2Cl2:CH3OH as 
the mobile phase. The product was recovered as an yellow oil. ( 0.759 g, 44.8% yield) 1H 
NMR (400 MHz, CDCl3)  ppm 7.13 (d, J=8.34 Hz, 2 H) 6.94 - 6.99 (m, 2 H) 5.32 (s, 3 
H) 4.63 - 4.71 (m, 2 H) 4.19 (dd, J=7.07, 1.77 Hz, 2 H) 3.11 (dd, J=15.66, 5.81 Hz, 2 H) 
2.50 (t, J=2.53 Hz, 1 H) 1.27 (t, J=7.20 Hz, 3 H). 
O
O
HN
N3
O
O
OH
O
HN
N3
O
O
1 M KOH
MeOH
17 18
 
 (S)-3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy)carbonyl)amino)propanoic acid (18) 
  Compound 17 (730 mg, 2.31 mmol) was dissolved in methanol (15 mL) and 
treated with aqueous 1M KOH (3.46 mL, 3.46 mmol) overnight.  The solution was 
neutralized with 1M citric acid (5 mL) and concentrated. The residue was diluted with 
water (10 mL) and acidified to pH equal to 2 with 1M citric acid monitored using pH 
paper. The resulting mixture was extracted into CH2Cl2 and the solvent was removed in 
vacuo. The product was recovered as an yellow oil. (0.3985 g, 49 % yield) 1H NMR (400 
MHz, CDCl3)  ppm 7.14 - 7.21 (m, 2 H) 6.99 (d, J=8.34 Hz, 2 H) 5.27 - 5.34 (m, 8 H) 
4.65 - 4.71 (m, 2 H) 3.22 (dd, J=14.02, 5.43 Hz, 8 H) 3.05 - 3.15 (m, 6 H) 2.51 (t, J=2.40 
Hz, 6 H) 1.41 - 1.50 (m, 14 H). 
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 (S)-Tert-butyl (3-(3-(4-azidophenyl)-2-(((prop-2-yn-1-
yloxy)carbonyl)amino)propanamido)propyl)(4-((tert-butoxycarbonyl)(3-
((tert-butoxycarbonyl)amino)propyl)amino)butyl)carbamate (19) 
  Compound 18 (31 mg, 0.108 mmol) was dissolved in CH2Cl2 (5 mL) along with 
EDC (27 mg, 0.140 mmol) and HOBt (21 g, 0.140 mmol) for 15 minutes, then triBoc 
spermine (54 mg, 0.108 mmol) was added. The reaction mixture was placed under argon 
and stirred overnight at room temperature.  The solvent was evaporated and the crude 
mixture was taken up in ethyl acetate (10 mL) and underwent an acid/base extraction 
with 1 N HCl (2x 10 mL) and 1 N NaOH (2x10 mL). The organic fraction was dried over 
anhydrous sodium sulfate, filtered, and the solvent was removed in vacuo. The product 
was recovered as a white solid. (43 mg, 51.7% yield) LCMS=772.9 
N3
N
H
N
N
H
N
NH
O
OO
O O
O
O
1 M anh 
HCl N3 HN O
O
HN
O
H
N
N
H
NH2
19 20 Probe3
O
O
 
 (S)-(3-(3-(4-azidophenyl)-2-(((prop-2-yn-1-yloxy) carbonyl) 
amino)propanamido)propyl) (4-(carboxy(3-(carboxyamino) 
propyl)amino)butyl) carbamic acid (20) 
  Compound 19 (43 mg, 0.0557 mmol) was taken up in 200 proof ethanol (3 mL) 
and acetyl chloride (0.75 mL) was added in dropwise to produce a 1M anhydrous HCl 
solution. The reaction was stirred overnight, hexanes (1 mL) was added to precipitate the 
product, and solvent was removed in vacuo. The product was recovered as an yellow oil. 
(36.7 mg, 90 % yield)  LCMS= 472.8 
4.4.3 Chemical Activity Based Protein Profiling on Bovine Serum Albumin and Lysozyme 
  5 µL of 2.0 mg/mL BSA or lysozyme was placed in 50 µL of 1x PBS and 1 mM 
of nanoprobe 3.  Samples were irradiated for 4 minutes with 365 nm light. Control non-
irradiated samples were also prepared.  Samples were then subjected to chemical ABPP. 
Master mixes for click solutions were set up with 1 mM CuSO4*5H2O (50 mM stock), 
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100 µM THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock).  
These incubated for 10 minutes and 10 µM of rhodamine azide. A separate control master 
mix was prepared by substituting deionized water in for the CuSO4*5H2O.. Samples were 
then separated on a 10% SDS-PAGE gel and fluorescence was measured using a 
Typhoon 9210 imager.  
4.4.4 Dissociated Culture of Rat Cortex, Midbrain, and Cerebellar Neurons 
  Primary dissociated cortex, midbrain, and cerebellar cell cultures were prepared 
from embryonic day E18-20 Sprague-Dawley rat embryos and were cultured on 25 cm2 
T-Flasks or 60 mm2 petri dishes coated in poly-lysine in serum containing media 
identical to previous reports.10 Cerebellar culture media was supplemented with 1M 
potassium chloride (1 mL in 50 mL).11 Cells were grown in 5% CO2  at 37°C. All animal 
care and experimental protocols were approved by the Animal Care and Use Committee 
at University of Massachusetts, Amherst, Amherst, MA, USA. 
4.4.5 Chemical Activity Based Protein Profiling on Rat Cortex, Midbrain, and Cerebellar 
Neurons 
  Cultures of neurons from of cortex, mid-brain, and cerebellum were grown on 25 
cm2 T-flasks (or 60 mm2 petri dishes) were grown to a point where they were synaptically 
active (DIV 14-18).  Flasks were washed three times with extracellular recording buffer. 
5 mL of 10 µM of nanoprobe 3 in extracellular solution with 20 µM glutamate was 
applied for 5 minutes at room temperature. Cells were then irradiated with 365 nm light 
for 4 minutes. Control samples were prepared either by non-irradiation with UV light or 
as equimolar mixtures of NAS and nanoprobe 3 with and without UV light. Flasks were 
then washed three more times with extracellular solution.  To this, 1 mL of lysis solution 
(1x PIC, 1x PBS) was added to each flask and cells were scrapped to remove from sides 
of the T-flask. Cells were lysed with a probe sonicator 30% power for 1 minute, and the 
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membrane portions were pelleted.  The membrane pellet was lysed again using the same 
conditions and a BCA assay was run to quantitate protein concentrations.  Master mixes 
for click solutions were prepared with 1 mM CuSO4*5H2O (50 mM stock), 100 µM 
THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock).  These 
lysates were incubated for 10 minutes and 10 µM of either rhodamine azide or biotin 
azide were then added. A separate control master mix was prepared by substituting 
deionized water in for the CuSO4*5H2O. To an Eppendorf tube, 50 µL of cell lysate and 
the appropriate master mix were added to the tube with the reaction going for one hour. 
Samples were then separated on a 10% SDS-PAGE gel.  For in-gel fluorescence 
experiments, gels were placed into 10% acetic acid and imaged using a Typhoon 9210 
imager.  For Western blot experiments, proteins were transferred to a nitrocellulose 
membrane and probed against streptavidin HRP.  HRP was activated using SuperSignal 
West Pico Chemiluminescence Substrate. Chemiluminescence was measured using a 
BioRad imaging system. 
4.4.6 Dissociated Culture of Rat Hippocampal and Cerebellar Neurons 
Primary dissociated cerebellar cell cultures were prepared from embryonic day 
E18-19 Sprague-Dawley rat embryos and were cultured on polylysine-coated coverglass 
(12mm, 1.0 size) in serum-containing media identical to previous reports. 11 Cells were 
grown in 5% CO2 at 37°C. All animal care and experimental protocols were approved by 
the Animal Care and Use Committee at the University of Massachusetts Amherst, 
Amherst, MA, USA. 
4.4.7 Fixed Cell Imaging of Rat Hippocampal and Cerebellar Neurons 
  Coverslips containing neurons were grown until they were synaptically active 
(DIV 14-18).  Three imaging solutions were prepared: a sham solution containing 4 mL 
of 1x ECS and 20µM l-glutamate, 8 mL of 10 µM of nanoprobe 3 in 1x ECS with 20 µM 
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l-glutamate, and 8 mL of  equimolar 10 µM nanoprobe 3 and NAS in 1x ECS with 20 
µM l-glutamate.  Coverslips were washed three times with 1x ECS and probe solutions 
were applied for 5 minutes at room temperature.  Appropriate coverslips were irradiated 
with UV (365nm) light for 4 minutes, and dark controls were left in the dark for the same 
amount of time.  Coverslips were then washed three times with 1x ECS. All coverslips 
were fixed in 4% paraformaldehyde for 8 minutes and were then washed three times with 
1x PBS. Click solutions (1 mM CuSO4*5H2O (50 mM stock), 100 µM THPTA (1.7 mM 
stock), freshly prepared 1 mM TCEP (50 mM stock), and 10 µM rhodamine azide (10 
mM stock)) were placed onto the coverslips. Control solutions were also prepared using 
deionized water in place of CuSO4*5H2O. Coverslips were then washed six times with 1x 
PBS and mounted onto coverglass using ProLong Gold Antifade. Coverslips cured 
overnight and were sealed using clear nail polish.  
  Hippocampal and cerebellar neurons were imaged by excitation with a light from 
a Sutter Lambda-LS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse 
Ti series microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA 
oil objective lens (Nikon) was employed for all imaging epifluorescence experiments. 
The Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and 
575 ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images 
were acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City, 
Japan) and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA). 
  Images were analyzed using ImageJ (U.S. National Institutes of Health, 
Bethesda, MD, USA).  The mean of the minimum and maximum overall fluorescence 
values were set for all images collected from each of the 16 coverslips (32 in all).  Images 
were not further analyzed as analysis by eye could tell there were differences between the 
nanoprobe 3 and control images. 
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4.4.8 Cell Culture of GluA1 CHO Cells 
  A stable cell line was prepared by Nate Johnson in the lab. Cells were grown to 
they were 70% confluent on cover glass (12mm, 1.0 size) in Hams-F12 media containing 
10% FBS.  Cells were grown at 5 % CO2 at 37°C.  
4.4.9 Fixed Cell Imaging of GluA1 CHO Cells 
Coverslips containing CHO cells were grown until they were 70-85% confluent. 
Two imaging solutions were prepared: 8 mL of 10 µM of nanoprobe 3 in 1x ECS with 20 
µM l-glutamate, and 8 mL of equimolar 10 µM nanoprobe 3 and NAS in 1x ECS with 20 
µM l-glutamate.  Coverslips were washed three times with 1x ECS and probe solutions 
were applied for 5 minutes at room temperature.  Appropriate coverslips were irradiated 
with UV (365nm) light for 4 minutes, and dark controls were left in the dark for the same 
amount of time.  Coverslips were then washed three to twenty four times with 1x PBS for 
washing experiments. For depolarization experiments, cells were washed one to four 
times with 1M KCl, washing three times with 1x PBS in between each addition.  
All coverslips were fixed in 4% paraformaldehyde for 10 minutes and were then 
washed three times with 1x PBS. Click solutions (1 mM CuSO4*5H2O (50 mM stock), 
100 µM THPTA (1.7 mM stock), freshly prepared 1 mM TCEP (50 mM stock), and 10 
µM rhodamine azide (10 mM stock)) were placed onto the coverslips. Control solutions 
were also prepared using deionized water in place of CuSO4*5H2O. Coverslips were then 
washed six times with 1x PBS and mounted onto coverglass using ProLong Gold 
Antifade. Coverslips cured overnight and were sealed using clear nail polish.  
  GluA1 CHO cells were imaged by excitation with a light from a Sutter Lambda-
LS illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti series 
microscope (Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 60X 1.4 NA oil 
objective lens (Nikon) was employed for all imaging epifluorescence experiments. The 
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Cy-3 filter cue contained a 540/30 excitation filter, a 570 DRLP dichroic mirror, and 575 
ALP emission filter (all from Omega Optical Corp., Brattleboro, VT, USA). Images were 
acquired using a Hamamatsu ORCA ER camera (Hamamatsu, Hamamatsu City, Japan) 
and NIS Elements BR 3.1 software (Nikon Corps, Melville, NY, USA). 
  Images were analyzed using ImageJ (U.S. National Institutes of Health, 
Bethesda, MD, USA).  The mean of the minimum and maximum overall fluorescence 
values were set for all images collected from each of the coverslips.  
4.4.10 Chemical Activity Based Protein Profiling of GluA1 CHO Cells  
   60 mm2 petri dishes of GluA1 CHO cells and CHO cells were grown until they 
were 90% confluent.  Petri dishes were washed three times with extracellular recording 
buffer. 5 mL of 10 µM of nanoprobe 3 in extracellular solution with 20 µM glutamate 
was applied for 5 minutes at room temperature. Cells were then irradiated with 365 nm 
light for 4 minutes. Control samples were prepared either by non-irradiation with UV 
light. Control non-transfected samples were treated for 5 minutes with TCEP and 
incubated with 10 µM malemide alkyne for 30 minutes at 37°C.  Petri dishes were then 
washed three more times with extracellular solution.  1 mL of lysis solution (1 x PIC, 1x 
PBS) was added to each dish and cells were scrapped to remove cells from the bottom of 
the dish. Cells were lysed with a probe sonicator 30% power for 1 minute, and the 
membrane portions were spun down.  The membrane pellet was lysed again using the 
same conditions and a BCA assay was run to quantitate protein concentrations.  Master 
mixes for click solutions were set up with 1 mM CuSO4*5H2O (50 mM stock), 100 µM 
THPTA (1.7 mM stock), and freshly prepared 1 mM TCEP (50 mM stock).  These 
incubated for 10 minutesutes and 10 µM of either rhodamine azide or biotin azide were 
then added. A separate control master mix was prepared by substituting deionized water 
in for the CuSO4*5H2O.  50 µL of cell lysate were removed and the appropriate master 
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mix was added to the tube with the reaction going for one hour. Samples were then 
separated on a 10% SDS-PAGE gel. For Western blot experiments, proteins were 
transferred to a nitrocellulose membrane and probed against streptavidin HRP.  HRP was 
activated using SuperSignal West Pico Chemiluminescent Substrate. Chemiluminescence 
was measured using a BioRad imaging system. 
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CHAPTER 4  
LABELING OF BIOLOGICAL SYSTEMS USING PHOTOGENERATED DIAZONIUMS 
5.1 Introduction 
  Understanding and visualizing how proteins react in vivo has become a popular 
topic in the past 15 years. Current methods for labeling biological systems involve either 
modifying the protein of interest with a fluorescent reporter or by targeting the protein 
using small-molecule probes which contain organic fluorophores. These organic 
fluorophores can more easily be changed out for different imaging experiments when 
compared to genetic manipulations.  Further, one has the ability to modify biomolecules 
such as glycans and lipids using bioorthoginal strategies.  A typical chemical probe 
contains a targeting ligand, a reactive partner for attachment, and a reporter tag for 
visualization.  These probes are designed in such a way that is orthogonal to the function 
of the receptor, termed bioorthogonal chemistry. There are a number of reactions that fall 
under the term bioorthogonal chemistry, including 1,3-dipolar cycloadditions (click 
reactions), hydrazine/oxime formation from aldehydes and ketones, tetrazine ligation, 
isocyanide based click reactions, and quadricyclane ligation.1 A full discussion of these 
can be found in section 1.3. Use of bioorthogonal probes is a two-step process in which 
the probe targets the protein of interest and then a reporter tag is added for visualization. 
  A well designed probe for bioorthogonal chemistry is one that will not interrupt 
function of the biomolecule target, can withstand the environment of the cell, yet can still 
react with its intended target, and the reaction does not produce a toxic byproduct.2 One 
of the most common type of bioorthogonal reactions is the 1,3-dipolar cycloaddition. 
Click reactions involve the reaction of an azide labeled moiety forming a triazole with an 
alkyne labeled moiety.  These reactions can be copper mediated or strain mediated.  
Strain mediated cycloadditions have been used in a variety of bio-systems such as 
proteins, live-cells, and living animals,3 and are preferable over copper mediated 
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reactions as there is no introduction of toxic amounts of copper to promote triazole 
formation.  However, when using strain-mediated cylcoadditions the biosystem of 
interest must be labeled with a bioorthogonal group, such as an azide. Most of the time, 
this means an azido sugar is fed to the organism, or the protein is covalently labeled with 
an azide.  Also, the cylcooctyne containing reporter tag can undergo attack by thiols 
contained on the biosystem of interest, thus leading to conjugation in areas not targeted 
by the reporter.2 
  Another method of tagging a biosystem of interest is through the use of 
photoaffinity labeling. This includes the use of benzophenones, aryl azides, and 3-
(trifluoromethyl)-3-phenyldiazirine.4  Photoreactive probes can provide spatial 
information about how proteins interact with each other. This is due to the indiscriminate 
nature of the activated photophore, as it will react with the nearest neighboring 
molecule.4  The aspects of a good photoprobe were covered in Section 4.1, and share 
overlap with the aspects of a good bioorthogonal probe listed above; chiefly, the probe 
not interfering with the mechanism of action of the protein of interest.  An ideal probe for 
looking at protein interactions with high spatial-temporal resolution should then 
incorporate aspects from both photoaffinity labeling and bioorthoginal reactivity.  
Aryl diazonium salts have been used to photolabel a number species due to their 
ability to undergo nucleophilic aromatic substitutions.4-5 Upon photolysis, the aryl 
diazonium generates a highly reactive aryl cation, which is super-reactive and will not 
rearrange in the excited state. They also bind to the closest nucleophilic partner, including 
C-H bonds, quickly, so that there is little time for them to exit from the active site of the 
receptor of interest. 6 
  A few attempts at this exact design have been produced and have been termed 
“photoclick” probes.  Lin in 2008 7 used terminal alkenes to induce photoactivated, nitrile 
imine mediated 1,3-dipolar cycloadditions in E. coli. Their method involved 
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incorporating O-allyl-tyrosine into E.coli Z-domain and applying probe molecules 
containing diaryl tetrazoles. After a 10 min irradiation with UV-light and SDS-PAGE 
analysis, they were able to tag their modified E. coli proteins. 7  In 2009, Poptik designed 
a photo-caged cyclooctyne by masking the alkyne as a photo-reactive cyclopropenone.  
Upon irradiation, the cyclopropenone transforms to the cyclooctyne which is ready for 
conjugation with an azide. In their cell experiments, CHO cells were grown with n-
azidoacetylmannosamine to produce the metabolite n-azido-diacetyl-sialic acid. Their 
protected biotinylated probes were incubated with cells for an hour, irradiated with UV 
light for 1 minute, and then incubated for an additional hour to facilitate the cycloaddition 
reaction.  CHO cells were then fixed and stained with avidin-FITC for detection.8 This 
cyclopropenone protected cyclooctyne method was then further adapted for use with 
enzyme mediated azide ligation.9 
  These methods extend the idea of “photoclick” reaction, but still rely on the 
biosystem of interest being tagged in some fashion with the bioorthogonal group days 
beforehand.  This is done by manipulation of the system with either a point mutation or 
by having the cell produce an azido metabolite.  A probe which quickly targets a 
biomolecule of interest produces an active, targetable species upon irradiation, and 
specifically couples with an appropriate reporter is still desired. 
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5.2 Results 
5.2.1 Live Cell Imaging of CHO Cells Using Oleic TBA and Cy-3 DHPP 
 
   
Our new probe is based upon an oleic acid scaffold as it will partition into the 
cell membrane. (Figure 5.1) Other directly fluorescent probes have been made from this 
scaffold. 10 Our probe incorporates oleic acid so it contains an ortho-triazine benzonic 
acid head group which is able to undergo photochemistry yielding a diazonium 
carboxylate. Our targeting molecule is Cy-3 DHPP, (Cy-3 dihydroxyphenyl piperazine, 
Figure 5.1) which contains an electron rich aromatic ring for attachment to the 
photogenerated diazonium species. CHO cells were incubated with 10 µM oleic TBA for 
15 minutes at 37°C in their home media. They were then washed via perfusion and 
photolysed.  1 µM Cy-3 DHPP was added for 15 seconds and cells were washed for 2 
minutes before fluorescence images were captured. Controls were performed using 
DMSO as a sham treatment. We saw very little difference in the treated versus sham 
treated cells. (Figure 5.2) 
Figure 5.1: Structure of Oleic TBA and Cy-3 DHPP 
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5.2.2 Live Cell Imaging of CHO Cells Using Oleic TBA and Cy-3 DMAPP 
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It was clear to us that the DHPP scaffold was far too reactive, so we decided to 
move to one that might be less so. Our new reporter tag was now Cy-3 DMAPP 
(dimethylaminophenyl piperazine, Figure 5.3) As before, CHO cells were incubated in 
their home media for 15 minutes with 1 µM oleic TBA, washed via perfusion, and 
photolysed for 15 seconds. Cy-3 DMAPP was applied for 15 seconds, and cells were 
Figure 5.2: CHO cells labeled with oleic TBA and Cy-3 DHPP. CHO cells 
were incubated 10 µM oleic TBA for 15 min at 37°C and 1 µM Cy-3 
DHPP for 15 seconds.  Controls were done with DMSO. There was 
not a significant increase in fluorescence over the controls. 
Figure 5.3: Structure of Cy-3 DMAPP 
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washed for 2 minutes. Fluorescence images were then collected. Sham DMSO treatments 
were also conducted as controls.  Again, we only saw slight differences in the probed 
cells versus those that had the sham treatment. (Figure 5.4)  
 
 
 
5.2.3 Live Cell Imaging of CHO Cells Using Oleic TBA and Biotin-DMAPP 
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We were not sure if it was our Cy-3 fluorophore itself that was crossing the 
membrane or otherwise being endocytosed by cells, so we decided to switch reporter 
Figure 5.4: Live CHO cell imaging with Cy-3 DMAPP.  CHO cells were 
incubated 1 µM oleic TBA for 15 min at 37°C and 1 µM Cy-3 
DMAPP  for  15 seconds.  Controls were done with DMSO. There 
was not a significant increase in fluorescence over the controls. 
Figure 5.5: Structure of biotin-DMAPP 
  
 
117 
tags. Our new probe contained the same electron-rich targeting core (DMAPP), but now 
had biotin installed for detection. (Figure 5.5) This allowed us to use an avidin-tagged 
fluorophore for fluorescence reporting as excess avidin will be washed away by 
perfusion.   CHO cells were incubated with 1 µM oleic-TBA for 15 minutes in their home 
media and washed via perfusion. Cells were then irradiated with UV light for 15 sec, and 
incubated with probe for 15 sec. Cells were then washed for 2 minutes, incubated with 
1:100 avidin-FITC 11 washed for another 2 minutes, and imaged fluorescently.  Controls 
this time were a DMSO sham and non-irradiated samples containing the probe. 
Fluorescent accumulation was seen along the cell membrane in irradiated cells, but not in 
the control samples. (Figure 5.6) 
 Figure 5.6: Live CHO cells imaged with oleic TBA and biotin-DMAPP. CHO cells were 
incubated 1 µM oleic TBA for 15 min at 37°C ,1 µM biotin DMAPP  for  15 
seconds, and 1:100 FITC avidin for 2 min .  Controls were done with DMSO and 
non-irradiation of oleic-TBA. Cells treated with both UV-light and avidin-FITC 
had an increase in fluorescence along membranes. 
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5.3 Discussion 
  Spatially and temporally controlled labeling of proteins using bioorthogonal 
methods is the future of where the field is heading in order to get real time information 
about protein dynamics and how cells function.  Currently, there are a few methods 
available in order to be able to achieve this, but they suffer from the need of having an 
orthogonal reporter tag installed either genetically or metabolically prior to photo 
activation.  Our approach is the first to develop a method that would allow for targeting a 
protein of interest target, then to target a photoactivated species with a reporter probe. To 
do so our targeting probe contained a triazine benzoic acid and our reporting probe 
containing an electron rich aromatic ring which attaches itself to a diazonium resulting 
from photolysis of the targeting probe. 
  The first version of the reporter probe contained a dihydroxyphenyl piperazine as 
our electron rich aromatic ring, conjugated to Cy-3 for visualization.  Application of the 
probe targeted areas on the cell membrane, but sham controls with DMSO also 
demonstrated fluorescence accumulation in the membrane as well. The same effect of 
fluorescent accumulation in the sham samples was also seen when the electron rich 
aromatic targeting group was changed to dimethylaminophenyl piperazine.  DMSO has 
been known to permeabilize membranes, 12 allowing for fluorophores to slowly leak in at 
higher concentrations of DMSO. Molecular dynamic simulations of lipid membranes 
with DMSO show that small pores can be formed in the dipalmitoyl-phosphatidylcholine 
bilayer, which could be a way for small molecules to get through the lipid bilayer. 12c, 13 It 
is also possible that the free fluorophore is diffusing across the cell membrane and 
accumulating in the cytosol. 14 
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   We decided to change our reporter tag to biotin so that we can then tag with an 
avidin labeled fluorophore.  The avidin labeled fluorophore should not cross the cell 
membrane, thus any fluorescence accumulation would be from avidin labeling biotin. We 
see precisely this result in our biotin DMAPP probed cells.  In control samples with 
DMSO, there was no fluorescence uptake. More importantly, there was no fluorescence 
accumulation when the oleic-TBA probe was not irradiated.  This strongly suggests that 
there is only binding of the reporting probe, when the targeting probe has been 
photoactivated, indicating that our probe is capable of photoclick chemistry.  This has 
also been confirmed in SDS-PAGE gels on acyl carrier protein (data not shown).   
Further probes would need to be ligand directed to confirm binding at specific sites, 
rather than global membrane binding. 
5.4 Methods 
5.4.1 General Imaging Methods 
  CHO cells were imaged by excitation with a light from a Sutter Lambda-LS 
illuminator (Sutter Instruments, Novato, CA,USA). A Nikon Eclipse Ti series microscope 
(Nikon Corps, Tokyo, Japan) with a CFI Plan Apo VC 40X objective lens (Nikon) was 
employed for all imaging epifluorescence experiments. The Cy-3 filter cube contained a 
540/30 excitation filter, a 570 DRLP dichroic mirror, and 575 ALP emission filter (all 
from Omega Optical Corp., Brattleboro, VT, USA). The GFP filter cube contained a 
470/40 excitation filter, 485 LP mirror, and a 525/50 emission filer (Filter series 49002, 
Chroma Corps, Bellows Falls, VT, USA).  Images were acquired using a Hamamatsu 
ORCA ER camera (Hamamatsu, Hamamatsu City, Japan) and NIS Elements BR 3.1 
software (Nikon Corps, Melville, NY, USA).  
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5.4.2 CHO Cell Culture 
  CHO cells were grown on coverglass (12.0 mm, size 1.0) until they were 70% 
confluent. They were maintained in Hams F-12 media containing 5% serum at 37 °C and 
5% CO2.   
5.4.3 Live CHO Cell Imaging with Oleic TBA and Cy-3 DHPP 
  CHO cells were incubated in their home media with 10 µM Oleic TBA for 15 
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus 
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and 
were bathed in extracellular recording buffer.  Cells were irradiated with UV light for 15 
seconds. After irradiation, 400 µL of a 1 µM Cy-3 DHPP for 30 seconds and then washed 
for 2 minutes with extracellular solution via perfusion.  Fluorescence images were then 
taken using the Cy-3 filter cube. Controls were performed in the same way by using 
DMSO in place of Oleic TBA. 
5.4.4 Live CHO Imaging with Oleic TBA and Cy-3 DMAPP 
  CHO cells were incubated in their home media with 10 µM Oleic TBA for 15 
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus 
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and 
were bathed in extracellular recording buffer.  Cells were irradiated with UV light for 15 
seconds and 250 µL of 1µM Cy-3 DMAPP were applied for 30 seconds.  Cells were then 
washed with extracellular solution via perfusion for 5 minutes.  Fluorescence images 
were then taken using the Cy-3 filter cube. Controls were performed using DMSO in 
place of Oleic TBA. 
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5.4.5 Live CHO Cell Imaging with Oleic TBA and Biotin-DMAPP 
  CHO cells were incubated in their home media with 10 µM Oleic TBA for 15 
minutes at 37 °C. Cells were removed and then mounted in 12 mm perfusion apparatus 
(Warner Instruments, P-3, RC-25, Warner Instruments LLC, Hamden, CT, USA) and 
were bathed in extracellular recording buffer.  Cells were irradiated with UV light for 15 
seconds, incubated with 250 µL of 1µM biotin DMAPP for 15 seconds, washed for 2 
minutes with extracellular solution via perfusion, incubated with Avidin-FITC 
(BioLegend, San Diego, CA, USA) for 2 minutes, and washed for 2 minutes again with 
perfusion. Fluorescence images were then taken. Controls were performed with DMSO in 
place of the Oleic TBA and with no UV irradiation. 
5.4.6 Image Analysis of Fluorescence Images  
  Images were analyzed using ImageJ (U.S. National Institutes of Health, 
Bethesda, MD, USA).  Fluorescence was quantified using ROI (region of interest) 
analysis over the whole cell areas. The images were background subtracted and the data 
was quantified using GraphPad Prism (La Jolla, CA, USA).   
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CHAPTER 5 
FUTURE DIRECTIONS AND CONCLUSIONS 
6.1 Conclusions for Nanoprobe Project 
  Our experiments with nanoprobe 1 suggest that this photolabile polyamine probe 
could be potentially targeting calcium permeable AMPARs. This was based on our 
promising imaging data which showed fluorescence accumulation in areas where 
AMPARs are known to aggregate and the fact that known AMPAR antagonists could 
block fluorescence accumulation.  However, using SDS-PAGE analysis of neuronal cell 
lysate labeled with nanoprobe 1 multiple bands were observed (Section 2, Figure 2.9).  
Taken together, these results suggest that we needed to develop a probe that would be 
better targeted towards calcium permeable AMPARs. 
  To allow for identification of specific subunits, we developed nanoprobe 2 which 
simplified our synthetic design and resulted in a probe which more closely resembles the 
natural toxin. We also designed nanoprobe 2 so that it would be amendable for proteomic 
experiments.  Nanoprobe 2, much like nanoprobe 1, relies on an acrylamide electrophile 
to bioconjugation to the surface of the receptor.  In preliminary imaging experiments, we 
were able to target the same receptors as nanoprobe 1 as the fluorescence accumulation 
looked to be similar.  We then moved into doing pull-down experiments with nanoprobe 
2 labeled neuronal proteins.  The result of the gels is that nanoprobe 2 did not label 
proteins like we saw with nanoprobe 1.  This could be due to the electrophile not being 
able to find a suitable nucleophillc partner to be able to bind on the surface of the protein. 
  We then decided to keep the same probe design, but swap out the electrophile for 
nanoprobe 3. In this design, we used an aryl azide for our electrophile.  The 
photoactivated aryl azide is more reactive than the acrylamide, 1 so finding a suitable 
nucleophilic partner should not be an issue. Initial testing of nanoprobe 3 in soluble 
protein showed that the photolysis and click chemistry conditions work. Moving into 
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neuronal proteins, nanoprobe 3 was, however, found to not bind either. Aryl azides are 
indiscriminate in their reactivity, and tend to react to their nearest neighbor. In this case, 
it is possible that the nearest neighbor was a water molecule inside the binding pocket 
and not the C-H of a proximal amino acid.  Without the covalent attachment to the C-H 
of the nearest amino acid, nanoprobe 3 would simply be washed away by the many wash 
steps involved in the pull down experiment. 
  One of the main reasons for why neither nanoprobe 2 nor nanoprobe 3 was able 
to covalently conjugate to the receptor was mainly due to the position of the electrophile.  
In nanoprobe 1 the electrophile and the targeting polyamine ligand were separated far 
from each other as they were on either side of the ANI core.  In both nanoprobe 2 and 
nanoprobe 3 the ligand and the electrophile are much closer to each other, as the ligand is 
eighteen bonds away from the electrophile in nanoprobe 1 and only nine in nanoprobe 2, 
eight in nanoprobe 3.   This placed the electrophile closer into the ligand binding pocket, 
thus it might have not been able to find a good nucleophilic binding partner or would just 
bind to water.  One way to remedy this would be to move the electrophile away from the 
targeting ligand. 
6.2 Future Directions for Nanoprobes 
  One of the ways that our nanoprobes can be redesigned is already occurring in 
the Chambers lab.  This is through the use of modular nanoprobes that are able to 
undergo click chemistry for ligand attachment. The core of these nanoprobes is the same 
as nanoprobe 1, except there is an alkyne handle in the ligand attachment point. (Figure 
6.1)  Attachment of the targeting polyamine ligand has been a very tricky synthetic step 
in the synthesis of all nanoprobes, but there are other targeting ligands available.  These 
ligands are not polyamine based but still act as use-dependent open ion channel blockers 
of AMPA receptors and they include molecules such as IEM 1925 and GYKI 52466 
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(Figure 6.1).  These molecules both contain primary amines which could be modified 
using a small acyl chain containing an azide for attachment to the nanoprobe scaffold 
through click chemistry methods.  This would provide us a few new targeting molecules 
which keep the electrophile in the same position as nanoprobe 1. 
 
 
6.2.1 Probe Design of Nanoprobe 4 
  One of the main reasons we chose the polyamine targeting ligand was due to the 
ability of the class of toxins to act as antagonists for calcium permeable AMPARs. A new 
probe containing a polyamine would need to move the ligand away from the electrophile 
in order for the electrophile to be able to explore similar chemical space to that of 
nanoprobe 1.  One way of doing so is to use naphthaleneacetic acid as our core for 
attachment of our electrophile, ligand, and reporter tag.  (Scheme 6.1) Naphthaleneacetic 
acid would first be nitrated and the nitro reduced to an amine for another attachment 
point. TriBoc spermine can then be peptide coupled to the carboxylic acid.  Tert-butyl 5-
((4-acrylamidobutyl)amino)-5-oxo-2-((prop-2-yn-1-ylamino)methyl)pentanoate would be 
synthesized from Boc-Glu(OMe)-OH, propargyl bromide, and 6-acrylamidohexanoic 
Figure 6.1: Structure of alkyne nanoprobe. A) Structure of alkyne nanoprobe, ANI core 
(pink) is attached to a carboxylic acid (green) for fluorophore diversity, and an 
acrylamide electrophile (red).  The alkyne handle (blue) allows for ligand 
diversity. B) AMPA receptor antagonists IEM 1925 and GYKI 52466. 
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acid.  This would then be peptide coupled to naphthaleneacetic acid to produce 
nanoprobe 4. 
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6.2.2 Quinoxaline Dione Probes for Calcium Permeable AMPAR Detection 
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Quinoxaline diones are another class of AMPA receptor antagonists. These 
include CBQX, DNQX, and NBQX. (Figure 6.2)  Potential probes for the detection of 
calcium permeable AMPARs could contain quinoxaline diones, specifically CBQX and 
DNQX, as targeting ligands.  One way of doing so, would be to attach an azide 
containing alkyl chain to the quinoxaline dione and then attach that to either the 
nanoprobe scaffold, or to the ortho-triazene benzoic acid scaffold.    
Scheme 6.1: Proposed synthesis for nanoprobe 5 
Figure 6.2: Quinoxaline diones 
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6.3 Conclusions to the Photogenerated Diazonium Probes 
  With our photogenerated diazonium probes we wanted to target photolabile 
bioorthogonal probes to the cell membrane.  This was done in an attempt to develop a 
probe that would have spatial and temporal control of reporter tag attachment to the probe 
in order to observe biological processes. We chose oleic acid conjugated to ortho-triazene 
benzoic acid to target towards biological membranes and an electron rich aromatic 
reporter tag. Our first version of the reporter tag used dihydroxyphenyl piperazine 
(DHPP) conjugated to Cy-3.  This reporter tag proved to be membrane permeable as 
control samples that only contained DMSO also had fluorescence activity.  We then 
altered the nucleophilic reporter to dimethylaminophenyl piperazine (DMAPP) 
conjugated to Cy-3 as our electron rich aromatic ring. As with the DHPP conjugated 
reporter tag, the DMAPP reporter tag also crossed the cell membrane in DMSO controls.  
This could be due to DMSO causing permeablization of cell membrane allowing for the 
reporter tag to cross the membrane.   
  We next decided to use a reporter tag that was conjugated with biotin in order to 
see if the initial concept of photoinducible cell tagging was occurring and was detectable.  
Biotin was chosen because it can be targeted with an avidin labeled fluorophore, which 
should not cross the cell membrane.  When the targeting probe was photoactivated, the 
biotin reporter probe will bind, and then be targeted with the avidin-labeled fluorophore.  
We see this with the new version of the DMAPP probe.  Fluorescence is seen only in the 
UV irradiated samples that contain the probe. 
  6.4 Future Directions for Photogenerated Probes 
  One of the main issues that needs to be perfected for the continued use of the 
photogenerated click probes is the targeting fluorophore.  The two scaffolds that were 
tried were also taken up by the DMSO sham controls cells.  These cells had fluorescence 
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accumulation that was equal to that of the ones that contained the targeting probe. If these 
probes are to be used further for imaging experiments, the use of a targeting probe that 
contains a fluorophore that does not cross the cell membrane would be crucial.  One way 
to do so might be to use dyes that are more hydrophobic so they would have a harder time 
passing through the membrane.  
The preliminary work with the photogenerated probes suggests that we can label 
live cells with our probes in a short time scale.  The probes in this case are not ligand 
directed; rather they are attached to a long chain fatty acid for incorporation to the cell 
membrane. The next step for these probes would be to attach a targeting ligand to target 
fluorescence to a particular receptor.  
  Since we are interested in AMPARs in the Chambers lab, the logical targeting 
ligand would be one that targets towards AMPARs.  The ortho-triazene benzoic acid 
portion of the targeting probe contains an alkyne handle for ligand attachment, so an 
azide labeled ligand can be attached.  In this case, we would try the same panel of azide 
labeled ligands as listed in Section 6.2 and 6.2.2. (azido IEM 1925, azido GYKI 52466, 
or an azido containing quinoxaline dione (Figure 6.3)). The acyl azide chain attached to 
GYKI 52466 is to the pendant phenyl, or as the pharmacophore dictates. Once these 
probes are synthesized, they can be applied to GluA1 CHO cell and then neurons to see if 
we can use this new photoclick method to target receptors.  
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